{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:17:44Z","timestamp":1794694664183,"version":"4.9.1"},"reference-count":528,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030060"],"award-info":[{"award-number":["82030060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Malaria, caused by <jats:italic>Plasmodium<\/jats:italic> parasites and transmitted by <jats:italic>Anopheles<\/jats:italic> mosquitoes, greatly impacts public health and socioeconomic development, particularly in sub-Saharan African countries. Despite advances in malaria treatment and prevention, the number of clinical cases and deaths have increased in recent years. The complex life cycle and genetic diversity of <jats:italic>Plasmodium<\/jats:italic> parasites pose significant challenges in drug and vaccine development, particularly due to the emerging partial resistance of parasites to artemisinin. With the availability and application of state-of-the-art biotechnology in recent years, knowledge in terms of parasite biology, pathogenicity, host\u2013parasite interactions and pathogenesis has advanced tremendously. This review highlights the most recent research progress and understanding in <jats:italic>Plasmodium<\/jats:italic> biology, with a primary focus on <jats:italic>P. falciparum<\/jats:italic> and associated pathogenesis. The therapeutic targets and progress in the clinical application of anti-malaria drugs have also been summarized. The FDA-approved regimens like Artemether-Lumefantrine, Atovaquone-Proguanil, and Primaquine are discussed, and their benefits and limitations are highlighted, especially in terms of drug resistance. Perspectives in the development of novel vaccines and new drugs, such as Sevuparin, Imatinib, and Cipargamin, and combination therapies with promise in overcoming resistance has been proposed. Overall, this review provides a detailed summary of the latest progress in malaria research and emphasizes the need for continuous monitoring and innovation in malaria treatment.<\/jats:p>","DOI":"10.1038\/s41392-025-02246-3","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T23:01:44Z","timestamp":1750114904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Malaria: past, present, and future"],"prefix":"10.1038","volume":"10","author":[{"given":"Qilong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunying","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyou","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0356-7435","authenticated-orcid":false,"given":"Qijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"2246_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1086\/432519","volume":"77","author":"DP Kwiatkowski","year":"2005","unstructured":"Kwiatkowski, D. P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77, 171\u2013192 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"2246_CR2","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1126\/science.8009217","volume":"264","author":"LH Miller","year":"1994","unstructured":"Miller, L. H., Good, M. F. & Milon, G. Malaria pathogenesis. Science 264, 1878\u20131883 (1994).","journal-title":"Science"},{"key":"2246_CR3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","volume":"167","author":"AF Cowman","year":"2016","unstructured":"Cowman, A. F., Healer, J., Marapana, D. & Marsh, K. Malaria: biology and disease. Cell 167, 610\u2013624 (2016).","journal-title":"Cell"},{"key":"2246_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04301-8","volume":"21","author":"NJ White","year":"2022","unstructured":"White, N. J. Severe malaria. Malar. J. 21, 284 (2022).","journal-title":"Malar. J."},{"key":"2246_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1128\/CMR.14.1.208-226.2001","volume":"14","author":"RS Phillips","year":"2001","unstructured":"Phillips, R. S. Current status of malaria and potential for control. Clin. Microbiol. Rev. 14, 208\u2013226 (2001).","journal-title":"Clin. Microbiol. Rev."},{"key":"2246_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40101-020-00251-9","volume":"40","author":"S Sato","year":"2021","unstructured":"Sato, S. Plasmodium\u2014a brief introduction to the parasites causing human malaria and their basic biology. J. Physiol. Anthropol. 40, 1 (2021).","journal-title":"J. Physiol. Anthropol."},{"key":"2246_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pt.2004.03.006","volume":"20","author":"M Mayxay","year":"2004","unstructured":"Mayxay, M., Pukrittayakamee, S., Newton, P. N. & White, N. J. Mixed-species malaria infections in humans. Trends Parasitol. 20, 233\u2013240 (2004).","journal-title":"Trends Parasitol."},{"key":"2246_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/CMR.00051-10","volume":"24","author":"T Bousema","year":"2011","unstructured":"Bousema, T. & Drakeley, C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin. Microbiol. Rev. 24, 377\u2013410 (2011).","journal-title":"Clin. Microbiol. Rev."},{"key":"2246_CR9","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/S2542-5196(19)30045-2","volume":"3","author":"KM Fornace","year":"2019","unstructured":"Fornace, K. M. et al. Environmental risk factors and exposure to the zoonotic malaria parasite Plasmodium knowlesi across northern Sabah, Malaysia: a population-based cross-sectional survey. Lancet Planet Health 3, e179\u2013e186 (2019).","journal-title":"Lancet Planet Health"},{"key":"2246_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04218-2","volume":"21","author":"L Paintain","year":"2022","unstructured":"Paintain, L. et al. Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure. Malar. J. 21, 203 (2022).","journal-title":"Malar. J."},{"key":"2246_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1506-0","volume":"15","author":"J Nonvignon","year":"2016","unstructured":"Nonvignon, J. et al. Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control. Malar. J. 15, 454 (2016).","journal-title":"Malar. J."},{"key":"2246_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025486","volume":"7","author":"AM Vaughan","year":"2017","unstructured":"Vaughan, A. M. & Kappe, S. H. J. Malaria parasite liver infection and exoerythrocytic biology. Cold Spring Harb. Perspect. Med. 7, a025486 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2246_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrmicro3111","volume":"11","author":"R M\u00e9nard","year":"2013","unstructured":"M\u00e9nard, R. et al. Looking under the skin: the first steps in malarial infection and immunity. Nat. Rev. Microbiol. 11, 701\u2013712 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"2246_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49080-9","volume":"15","author":"CF Markwalter","year":"2024","unstructured":"Markwalter, C. F. et al. Plasmodium falciparum infection in humans and mosquitoes influence natural Anopheline biting behavior and transmission. Nat. Commun. 15, 4626 (2024).","journal-title":"Nat. Commun."},{"key":"2246_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025569","volume":"8","author":"DA Milner Jr","year":"2018","unstructured":"Milner, D. A. Jr Malaria Pathogenesis. Cold Spring Harb. Perspect. Med. 8, a025569 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2246_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003359","volume":"17","author":"A Mousa","year":"2020","unstructured":"Mousa, A. et al. The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis. PLOS Med. 17, e1003359 (2020).","journal-title":"PLOS Med."},{"key":"2246_CR17","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley, E. A., Pyae Phyo, A. & Woodrow, C. J. Malaria. Lancet 391, 1608\u20131621 (2018).","journal-title":"Lancet"},{"key":"2246_CR18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11427-015-4948-7","volume":"58","author":"XZ Su","year":"2015","unstructured":"Su, X. Z. & Miller, L. H. The discovery of artemisinin and the Nobel Prize in Physiology or Medicine. sci. China Life sci. 58, 1175\u20131179 (2015).","journal-title":"sci. China Life sci."},{"key":"2246_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"B Blasco","year":"2017","unstructured":"Blasco, B., Leroy, D. & Fidock, D. A. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat. Med. 23, 917\u2013928 (2017).","journal-title":"Nat. Med."},{"key":"2246_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/096777200201000205","volume":"10","author":"ER Nye","year":"2002","unstructured":"Nye, E. R. Alphonse Laveran (1845-1922): discoverer of the malarial parasite and Nobel laureate, 1907. J. Med. Biogr. 10, 81\u201387 (2002).","journal-title":"J. Med. Biogr."},{"key":"2246_CR21","first-page":"257","volume":"49","author":"C Sundberg","year":"2007","unstructured":"Sundberg, C. Alphonse Laveran: the Nobel Prize for Medicine 1907. Parassitologia 49, 257\u2013260 (2007).","journal-title":"Parassitologia"},{"key":"2246_CR22","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/bmj.1.3624.1145","volume":"1","author":"JH Sequeira","year":"1930","unstructured":"Sequeira, J. H. Alphonse Laveran And His Work. Br. Med. J. 1, 1145\u20131147 (1930).","journal-title":"Br. Med. J."},{"key":"2246_CR23","volume":"16","author":"M Malpe","year":"2024","unstructured":"Malpe, M., Choudhari, S. G., Nagtode, N. & Muntode Gharde, P. The legacy of Sir Ronald Ross: from malaria research to multifaceted achievements. Cureus 16, e65999 (2024).","journal-title":"Cureus"},{"key":"2246_CR24","volume":"16","author":"V Pande","year":"2024","unstructured":"Pande, V., Bahal, M., Dua, J. & Gupta, A. Ronald Ross: pioneer of malaria research and nobel laureate. Cureus 16, e65993 (2024).","journal-title":"Cureus"},{"key":"2246_CR25","first-page":"245","volume":"86","author":"CJJulius Tsay","year":"2013","unstructured":"Tsay, C. J. J. ulius Wagner-Jauregg and the legacy of malarial therapy for the treatment of general paresis of the insane. Yale J. Biol. Med. 86, 245\u2013254 (2013).","journal-title":"Yale J. Biol. Med."},{"key":"2246_CR26","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1542\/peds.2005-1934","volume":"117","author":"TN Raju","year":"2006","unstructured":"Raju, T. N. Hot brains: manipulating body heat to save the brain. Pediatrics 117, e320\u2013e321 (2006).","journal-title":"Pediatrics"},{"key":"2246_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1126\/science.342.6159.686","volume":"342","author":"G Vogel","year":"2013","unstructured":"Vogel, G. Malaria as lifesaving therapy. Science 342, 686 (2013).","journal-title":"Science"},{"key":"2246_CR28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1021\/ja01221a051","volume":"67","author":"RB Woodward","year":"1945","unstructured":"Woodward, R. B. & Doering, W. The total synthesis of quinine. J. Am. Chem. Soc. 67, 860\u2013874 (1945).","journal-title":"J. Am. Chem. Soc."},{"key":"2246_CR29","unstructured":"Benfey, O. T. & Morris, P. J. T. Robert Burns Woodward: Architect and Artist in the World of Molecules (Chemical Heritage Foundation, 2001)."},{"key":"2246_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-144","volume":"10","author":"J Achan","year":"2011","unstructured":"Achan, J. et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar. J. 10, 144 (2011).","journal-title":"Malar. J."},{"key":"2246_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/anie.200400663","volume":"44","author":"TS Kaufman","year":"2005","unstructured":"Kaufman, T. S. & R\u00faveda, E. The quest for quinine: those who won the battles and those who won the war. Angew. Chem. Int. Ed. Engl. 44, 854\u2013885 (2005).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2246_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ajh.24314","volume":"91","author":"NW Liles","year":"2016","unstructured":"Liles, N. W. et al. Diversity and severity of adverse reactions to quinine: a systematic review. Am. J. Hematol. 91, 461\u2013466 (2016).","journal-title":"Am. J. Hematol."},{"key":"2246_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","volume":"57","author":"A Cortegiani","year":"2020","unstructured":"Cortegiani, A., Ingoglia, G., Ippolito, M., Giarratano, A. & Einav, S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J. Crit. Care 57, 279\u2013283 (2020).","journal-title":"J. Crit. Care"},{"key":"2246_CR34","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/322858","volume":"184","author":"TE Wellems","year":"2001","unstructured":"Wellems, T. E. & Plowe, C. Chloroquine-resistant malaria. J. Infect. Dis. 184, 770\u2013776 (2001).","journal-title":"J. Infect. Dis."},{"key":"2246_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0035-9203(45)90039-3","volume":"38","author":"P Buxton","year":"1945","unstructured":"Buxton, P. & Hygiene. The use of the new insecticide DDT in relation to the problems of tropical medicine. Trans. R. Soc. Trop. Med. Hyg. 38, 367\u2013400 (1945).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"2246_CR36","unstructured":"World Health Organization. Global Malaria Control and Elimination: Report of a Technical Review (2008)."},{"key":"2246_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14787210.2021.1962291","volume":"20","author":"C Rasmussen","year":"2022","unstructured":"Rasmussen, C., Alonso, P. & Ringwald, P. Current and emerging strategies to combat antimalarial resistance. Expert Rev. Anti Infect. Ther. 20, 353\u2013372 (2022).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"2246_CR38","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.3390\/jcm13195680","volume":"13","author":"M Thellier","year":"2024","unstructured":"Thellier, M., Gemegah, A. & Tantaoui, I. Global fight against malaria: goals and achievements 1900\u20132022. J. Clin. Med. 13, 5680 (2024).","journal-title":"J. Clin. Med."},{"key":"2246_CR39","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/S0140-6736(16)30261-6","volume":"387","author":"X Zhai","year":"2016","unstructured":"Zhai, X., Wang, Q. & Li, M. Tu Youyou\u2019s Nobel Prize and the academic evaluation system in China. Lancet 387, 1722 (2016).","journal-title":"Lancet"},{"key":"2246_CR40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.1155165","volume":"320","author":"N White","year":"2008","unstructured":"White, N. Qinghaosu (artemisinin): the price of success. Science 320, 330\u2013334 (2008).","journal-title":"Science"},{"key":"2246_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107658","volume":"216","author":"N Ma","year":"2020","unstructured":"Ma, N. et al. The birth of artemisinin. Pharm. Ther. 216, 107658 (2020).","journal-title":"Pharm. Ther."},{"key":"2246_CR42","unstructured":"World Health Organization. Global Technical Strategy for Malaria 2016\u20132030 (2015)."},{"key":"2246_CR43","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1016\/j.vaccine.2015.09.096","volume":"33","author":"TL Richie","year":"2015","unstructured":"Richie, T. L. et al. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine 33, 7452\u20137461 (2015).","journal-title":"Vaccine"},{"key":"2246_CR44","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.immuni.2017.11.007","volume":"47","author":"G Triller","year":"2017","unstructured":"Triller, G. et al. Natural parasite exposure induces protective human anti-malarial antibodies. Immunity 47, 1197\u20131209 (2017).","journal-title":"Immunity"},{"key":"2246_CR45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.6204383","volume":"225","author":"JB Dame","year":"1984","unstructured":"Dame, J. B. et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225, 593\u2013599 (1984).","journal-title":"Science"},{"key":"2246_CR46","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.2409595","volume":"228","author":"F Zavala","year":"1985","unstructured":"Zavala, F. et al. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228, 1436\u20131440 (1985).","journal-title":"Science"},{"key":"2246_CR47","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(87)90540-X","volume":"1","author":"WR Ballou","year":"1987","unstructured":"Ballou, W. R. et al. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1, 1277\u20131281 (1987).","journal-title":"Lancet"},{"key":"2246_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4161\/hv.6.1.9677","volume":"6","author":"J Cohen","year":"2010","unstructured":"Cohen, J., Nussenzweig, V., Nussenzweig, R., Vekemans, J. & Leach, A. From the circumsporozoite protein to the RTS, S\/AS candidate vaccine. Hum. Vaccin. 6, 90\u201396 (2010).","journal-title":"Hum. Vaccin."},{"key":"2246_CR49","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","volume":"16","author":"MRTS Laurens","year":"2020","unstructured":"Laurens, M. R. T. S. S\/AS01 vaccine (Mosquirix\u2122): an overview. Hum. Vaccin. Immunother. 16, 480\u2013489 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"2246_CR50","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","volume":"365","author":"ST Agnandji","year":"2011","unstructured":"RTS,S Clinical Trials Partnership, Agnandji, S. T. et al. First results of phase 3 trial of RTS, S\/AS01 malaria vaccine in African children. N. Engl. J. Med 365, 1863\u20131875 (2011).","journal-title":"N. Engl. J. Med"},{"key":"2246_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","unstructured":"RTS,S Clinical Trials Partnership Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31\u201345 (2015).","journal-title":"Lancet"},{"key":"2246_CR52","doi-asserted-by":"publisher","first-page":"1387078","DOI":"10.3389\/fitd.2024.1387078","volume":"5","author":"AF Lubanga","year":"2024","unstructured":"Lubanga, A. F. et al. Beyond RTS, S malaria vaccine piloting to adoption and historic introduction in sub-Saharan Africa: a new hope in the fight against the vector-borne disease. Front. Trop. Dis. 5, 1387078 (2024).","journal-title":"Front. Trop. Dis."},{"key":"2246_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0708-9","volume":"12","author":"KA Moser","year":"2020","unstructured":"Moser, K. A. et al. Strains used in whole-organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential. Genome Med. 12, 6 (2020).","journal-title":"Genome Med."},{"key":"2246_CR54","doi-asserted-by":"publisher","first-page":"e00019","DOI":"10.1128\/CMR.00019-19","volume":"32","author":"XZ Su","year":"2019","unstructured":"Su, X. Z., Lane, K. D., Xia, L., S\u00e1, J. M. & Wellems, T. E. Plasmodium genomics and genetics: new insights into malaria pathogenesis, drug resistance, epidemiology, and evolution. Clin. Microbiol. Rev. 32, e00019 (2019).","journal-title":"Clin. Microbiol. Rev."},{"key":"2246_CR55","doi-asserted-by":"publisher","first-page":"e008431","DOI":"10.1136\/bmjgh-2022-008431","volume":"7","author":"S Sharma","year":"2022","unstructured":"Sharma, S. et al. What India can learn from globally successful malaria elimination programmes. BMJ Glob. Health 7, e008431 (2022).","journal-title":"BMJ Glob. Health"},{"key":"2246_CR56","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1016\/S2468-2667(21)00201-2","volume":"6","author":"J Cao","year":"2021","unstructured":"Cao, J. et al. Achieving malaria elimination in China. Lancet Public Health 6, e871\u2013e872 (2021).","journal-title":"Lancet Public Health"},{"key":"2246_CR57","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","volume":"22","author":"MS Datoo","year":"2022","unstructured":"Datoo, M. S. et al. Efficacy and immunogenicity of R21\/Matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial. Lancet Infect. Dis. 22, 1728\u20131736 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-S1-O27","volume":"13","author":"T Eisele","year":"2014","unstructured":"Eisele, T. Are investments in malaria control saving the lives of children? Challenges in using all-cause child mortality for measuring the impact of malaria control programs. Malar. J. 13, O27 (2014).","journal-title":"Malar. J."},{"key":"2246_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-4-18","volume":"4","author":"I Adam","year":"2005","unstructured":"Adam, I., Khamis, A. H. & Elbashir, M. I. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women of eastern Sudan. Malar. J. 4, 18 (2005).","journal-title":"Malar. J."},{"key":"2246_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04881-7","volume":"23","author":"NK Kayiba","year":"2024","unstructured":"Kayiba, N. K. et al. Malaria infection among adults residing in a highly endemic region from the Democratic Republic of the Congo. Malar. J. 23, 82 (2024).","journal-title":"Malar. J."},{"key":"2246_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"MA Phillips","year":"2017","unstructured":"Phillips, M. A. et al. Malaria. Nat. Rev. Dis. Prim. 3, 17050 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2246_CR62","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13071-024-06457-5","volume":"17","author":"RA Ashton","year":"2024","unstructured":"Ashton, R. A. et al. Why does malaria transmission continue at high levels despite universal vector control? Quantifying persistent malaria transmission by Anopheles funestus in Western Province, Zambia. Parasites Vectors 17, 429 (2024).","journal-title":"Parasites Vectors"},{"key":"2246_CR63","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/cid\/ciac527","volume":"76","author":"B Andagalu","year":"2023","unstructured":"Andagalu, B. et al. Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population. Clin. Infect. Dis. 76, 704\u2013712 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-S1-S2","volume":"8","author":"G Kokwaro","year":"2009","unstructured":"Kokwaro, G. Ongoing challenges in the management of malaria. Malar. J. 8, S2 (2009).","journal-title":"Malar. J."},{"key":"2246_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04805-x","volume":"22","author":"MS Hossain","year":"2023","unstructured":"Hossain, M. S., Ahmed, T. S., Sultana, N., Chowdhury, M. A. B. & Uddin, M. J. Examining the disparities of anti-malarial drug consumption among children under the age of five: a study of 5 malaria-endemic countries. Malar. J. 22, 370 (2023).","journal-title":"Malar. J."},{"key":"2246_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(24)02706-5","volume":"405","author":"R Martinez-Vega","year":"2024","unstructured":"Martinez-Vega, R. et al. Regional action needed to halt antimalarial drug resistance in Africa. Lancet 405, 7\u201310 (2024).","journal-title":"Lancet"},{"key":"2246_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","volume":"18","author":"R Amato","year":"2018","unstructured":"Amato, R. et al. Origins of the current outbreak of multidrug-resistant malaria in Southeast Asia: a retrospective genetic study. Lancet Infect. Dis. 18, 337\u2013345 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR68","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1093\/infdis\/jiw363","volume":"214","author":"R Boyce","year":"2016","unstructured":"Boyce, R. et al. Severe flooding and malaria transmission in the western ugandan highlands: implications for disease control in an era of global climate change. J. Infect. Dis. 214, 1403\u20131410 (2016).","journal-title":"J. Infect. Dis."},{"key":"2246_CR69","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1073\/pnas.0601493103","volume":"103","author":"JA Patz","year":"2006","unstructured":"Patz, J. A. & Olson, S. H. Malaria risk and temperature: Influences from global climate change and local land use practices. Proc. Natl Acad. Sci. USA 103, 5635\u20135636 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2246_CR70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/tropicalmed8010067","volume":"8","author":"L Gao","year":"2023","unstructured":"Gao, L., Shi, Q., Liu, Z., Li, Z. & Dong, X. Impact of the COVID-19 pandemic on malaria control in Africa: a preliminary analysis. Trop. Med Infect. Dis. 8, 67 (2023).","journal-title":"Trop. Med Infect. Dis."},{"key":"2246_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1473-3099(20)30700-3","volume":"21","author":"DJ Weiss","year":"2021","unstructured":"Weiss, D. J. et al. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect. Dis. 21, 59\u201369 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04753-6","volume":"22","author":"HB Aguma","year":"2023","unstructured":"Aguma, H. B. et al. Mass distribution campaign of long-lasting insecticidal nets (LLINs) during the COVID-19 pandemic in Uganda: lessons learned. Malar. J. 22, 310 (2023).","journal-title":"Malar. J."},{"key":"2246_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04240-4","volume":"21","author":"G Kerr","year":"2022","unstructured":"Kerr, G., Robinson, L. J., Russell, T. L. & Macdonald, J. Lessons for improved COVID-19 surveillance from the scale-up of malaria testing strategies. Malar. J. 21, 223 (2022).","journal-title":"Malar. J."},{"key":"2246_CR74","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.1016\/S2214-109X(20)30210-2","volume":"8","author":"S Dittrich","year":"2020","unstructured":"Dittrich, S. et al. Diagnosing malaria and other febrile illnesses during the COVID-19 pandemic. Lancet Glob. Health 8, e879\u2013e880 (2020).","journal-title":"Lancet Glob. Health"},{"key":"2246_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2020.e00187","volume":"11","author":"A Zawawi","year":"2020","unstructured":"Zawawi, A. et al. The impact of COVID-19 pandemic on malaria elimination. Parasite Epidemiol. Control. 11, e00187 (2020).","journal-title":"Parasite Epidemiol. Control."},{"key":"2246_CR76","doi-asserted-by":"publisher","first-page":"e1004008","DOI":"10.1371\/journal.pgen.1004008","volume":"10","author":"RG Dorrell","year":"2014","unstructured":"Dorrell, R. G., Drew, J., Nisbet, R. E. & Howe, C. J. Evolution of chloroplast transcript processing in Plasmodium and its chromerid algal relatives. PLoS Genet. 10, e1004008 (2014).","journal-title":"PLoS Genet."},{"key":"2246_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijpara.2016.08.005","volume":"47","author":"GI McFadden","year":"2017","unstructured":"McFadden, G. I. & Yeh, E. The apicoplast: now you see it, now you don\u2019t. Int. J. Parasitol. 47, 137\u2013144 (2017).","journal-title":"Int. J. Parasitol."},{"key":"2246_CR78","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03272-19","volume":"11","author":"MC Siao","year":"2020","unstructured":"Siao, M. C., Borner, J., Perkins, S. L., Deitsch, K. W. & Kirkman, L. A. Evolution of host specificity by malaria parasites through altered mechanisms controlling genome maintenance. mBio 11, e03272 (2020).","journal-title":"mBio"},{"key":"2246_CR79","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/icb\/42.2.401","volume":"42","author":"AG Evans","year":"2002","unstructured":"Evans, A. G. & Wellems, T. E. Coevolutionary genetics of Plasmodium malaria parasites and their human hosts. Integr. Comp. Biol. 42, 401\u2013407 (2002).","journal-title":"Integr. Comp. Biol."},{"key":"2246_CR80","doi-asserted-by":"publisher","first-page":"587933","DOI":"10.3389\/fcimb.2020.587933","volume":"10","author":"XZ Su","year":"2020","unstructured":"Su, X. Z., Zhang, C. & Joy, D. A. Host-malaria parasite interactions and impacts on mutual evolution. Front. Cell Infect. Microbiol 10, 587933 (2020).","journal-title":"Front. Cell Infect. Microbiol"},{"key":"2246_CR81","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-024-07546-2","volume":"631","author":"M Michel","year":"2024","unstructured":"Michel, M. et al. Ancient Plasmodium genomes shed light on the history of human malaria. Nature 631, 125\u2013133 (2024).","journal-title":"Nature"},{"key":"2246_CR82","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12915-014-0086-0","volume":"12","author":"TD Otto","year":"2014","unstructured":"Otto, T. D. et al. A comprehensive evaluation of rodent malaria parasite genomes and gene expression. BMC Biol. 12, 86 (2014).","journal-title":"BMC Biol."},{"key":"2246_CR83","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s42003-020-1081-3","volume":"3","author":"RI Omelianczyk","year":"2020","unstructured":"Omelianczyk, R. I. et al. Rapid activation of distinct members of multigene families in Plasmodium spp. Commun. Biol. 3, 351 (2020).","journal-title":"Commun. Biol."},{"key":"2246_CR84","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature01097","volume":"419","author":"MJ Gardner","year":"2002","unstructured":"Gardner, M. J. et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498\u2013511 (2002).","journal-title":"Nature"},{"key":"2246_CR85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ympev.2007.11.012","volume":"47","author":"ES Martinsen","year":"2008","unstructured":"Martinsen, E. S., Perkins, S. L. & Schall, J. J. A three-genome phylogeny of malaria parasites (Plasmodium and closely related genera): Evolution of life-history traits and host switches. Mol. Phylogenet. Evol. 47, 261\u2013273 (2008).","journal-title":"Mol. Phylogenet. Evol."},{"key":"2246_CR86","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1755-0998.2009.02692.x","volume":"9","author":"S Bensch","year":"2009","unstructured":"Bensch, S., Hellgren, O. & P\u00e9rez-Tris, J. MalAvi: a public database of malaria parasites and related haemosporidians in avian hosts based on mitochondrial cytochrome b lineages. Mol. Ecol. Resour. 9, 1353\u20131358 (2009).","journal-title":"Mol. Ecol. Resour."},{"key":"2246_CR87","doi-asserted-by":"publisher","first-page":"17415","DOI":"10.1073\/pnas.1311016110","volume":"110","author":"J Schaer","year":"2013","unstructured":"Schaer, J. et al. High diversity of West African bat malaria parasites and a tight link with rodent Plasmodium taxa. Proc. Natl. Acad. Sci. USA 110, 17415\u201317419 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0923-4","volume":"15","author":"J Walk","year":"2017","unstructured":"Walk, J. et al. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial. BMC Med. 15, 168 (2017).","journal-title":"BMC Med."},{"key":"2246_CR89","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(01)06957-4","volume":"358","author":"KA Bojang","year":"2001","unstructured":"Bojang, K. A. et al. Efficacy of RTS, S\/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358, 1927\u20131934 (2001).","journal-title":"Lancet"},{"key":"2246_CR90","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1074\/jbc.272.5.2652","volume":"272","author":"CP Sanchez","year":"1997","unstructured":"Sanchez, C. P., W\u00fcnsch, S. & Lanzer, M. Identification of a chloroquine importer in Plasmodium falciparum: differences in import kinetics are genetically linked with the chloroquine-resistant phenotype. J. Biol. Chem. 272, 2652\u20132658 (1997).","journal-title":"J. Biol. Chem."},{"key":"2246_CR91","doi-asserted-by":"publisher","first-page":"e1000887","DOI":"10.1371\/journal.ppat.1000887","volume":"6","author":"SG Valderramos","year":"2010","unstructured":"Valderramos, S. G. et al. Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. PLoS Pathog. 6, e1000887 (2010).","journal-title":"PLoS Pathog."},{"key":"2246_CR92","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0166-6851(96)02718-1","volume":"81","author":"CJ Drakeley","year":"1996","unstructured":"Drakeley, C. J. et al. Geographical distribution of a variant epitope of Pfs4845, a Plasmodium falciparum transmission-blocking vaccine candidate. Mol. Biochem. Parasitol. 81, 253\u2013257 (1996).","journal-title":"Mol. Biochem. Parasitol."},{"key":"2246_CR93","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mib.2018.09.003","volume":"46","author":"M De Niz","year":"2018","unstructured":"De Niz, M. & Heussler, V. T. Rodent malaria models: insights into human disease and parasite biology. Curr. Opin. Microbiol. 46, 93\u2013101 (2018).","journal-title":"Curr. Opin. Microbiol."},{"key":"2246_CR94","doi-asserted-by":"publisher","first-page":"e1002320","DOI":"10.1371\/journal.pcbi.1002320","volume":"7","author":"C Frech","year":"2011","unstructured":"Frech, C. & Chen, N. Genome comparison of human and non-human malaria parasites reveals species subset-specific genes potentially linked to human disease. PLoS Comput. Biol. 7, e1002320 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"2246_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0010044","volume":"1","author":"TWA Kooij","year":"2005","unstructured":"Kooij, T. W. A. et al. A plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes. PLoS Pathog. 1, e44 (2005).","journal-title":"PLoS Pathog."},{"key":"2246_CR96","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.gde.2005.09.001","volume":"15","author":"N Hall","year":"2005","unstructured":"Hall, N. & Carlton, J. Comparative genomics of malaria parasites. Curr. Opin. Genet. Dev. 15, 609\u2013613 (2005).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2246_CR97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.187.1.15","volume":"187","author":"Q Chen","year":"1998","unstructured":"Chen, Q. et al. Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J. Exp. Med. 187, 15\u201323 (1998).","journal-title":"J. Exp. Med."},{"key":"2246_CR98","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw2619","volume":"365","author":"VM Howick","year":"2019","unstructured":"Howick, V. M. et al. The Malaria Cell Atlas: single parasite transcriptomes across the complete Plasmodium life cycle. Science 365, eaaw2619 (2019).","journal-title":"Science"},{"key":"2246_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.604129","volume":"11","author":"K Witmer","year":"2021","unstructured":"Witmer, K. et al. Using scRNA-seq to identify transcriptional variation in the malaria parasite Ookinete stage. Front. Cell Infect. Microbiol. 11, 604129 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2246_CR100","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-022-05406-5","volume":"611","author":"A Afriat","year":"2022","unstructured":"Afriat, A. et al. A spatiotemporally resolved single-cell atlas of the Plasmodium liver stage. Nature 611, 563\u2013569 (2022).","journal-title":"Nature"},{"key":"2246_CR101","doi-asserted-by":"crossref","unstructured":"Severe malaria. Trop. Med. Int. Health 19, 7\u2013131 (2014).","DOI":"10.1111\/tmi.12313_2"},{"key":"2246_CR102","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.2022.12366","volume":"328","author":"JP Daily","year":"2022","unstructured":"Daily, J. P., Minuti, A. & Khan, N. Diagnosis, treatment, and prevention of malaria in the US: a review. JAMA 328, 460\u2013471 (2022).","journal-title":"JAMA"},{"key":"2246_CR103","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jinf.2016.02.001","volume":"72","author":"DG Lalloo","year":"2016","unstructured":"Lalloo, D. G. et al. UK malaria treatment guidelines 2016. J. Infect. 72, 635\u2013649 (2016).","journal-title":"J. Infect."},{"key":"2246_CR104","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/j.1469-0691.2011.03639.x","volume":"17","author":"ML McMorrow","year":"2011","unstructured":"McMorrow, M. L., Aidoo, M. & Kachur, S. P. Malaria rapid diagnostic tests in elimination settings-can they find the last parasite?. Clin. Microbiol. Infect. 17, 1624\u20131631 (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"2246_CR105","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/cc2183","volume":"7","author":"A Trampuz","year":"2003","unstructured":"Trampuz, A., Jereb, M., Muzlovic, I. & Prabhu, R. M. Clinical review: severe malaria. Crit. Care 7, 315\u2013323 (2003).","journal-title":"Crit. Care"},{"key":"2246_CR106","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/cid\/ciab610","volume":"74","author":"A W\u00e5ngdahl","year":"2022","unstructured":"W\u00e5ngdahl, A. et al. Relapse of plasmodium vivax and plasmodium ovale malaria with and without primaquine treatment in a nonendemic area. Clin. Infect. Dis. 74, 1199\u20131207 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR107","doi-asserted-by":"publisher","first-page":"829413","DOI":"10.3389\/fcimb.2022.829413","volume":"12","author":"P Rosa-Gon\u00e7alves","year":"2022","unstructured":"Rosa-Gon\u00e7alves, P., Ribeiro-Gomes, F. L. & Daniel-Ribeiro, C. T. Malaria-related neurocognitive deficits and behavioral alterations. Front. Cell Infect. Microbiol. 12, 829413 (2022.","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2246_CR108","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1203\/PDR.0b013e3181eee738","volume":"68","author":"R Idro","year":"2010","unstructured":"Idro, R., Marsh, K., John, C. C. & Newton, C. R. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr. Res. 68, 267\u2013274 (2010).","journal-title":"Pediatr. Res."},{"key":"2246_CR109","doi-asserted-by":"crossref","unstructured":"Haldar, K. & Mohandas, N. Malaria, erythrocytic infection, and anemia. Hematol. Am. Soc. Hematol. Educ. Program, 87\u201393 (2009).","DOI":"10.1182\/asheducation-2009.1.87"},{"key":"2246_CR110","first-page":"186","volume":"2","author":"J Schantz-Dunn","year":"2009","unstructured":"Schantz-Dunn, J. & Nour, N. M. Malaria and pregnancy: a global health perspective. Rev. Obstet. Gynecol. 2, 186\u2013192 (2009).","journal-title":"Rev. Obstet. Gynecol."},{"key":"2246_CR111","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4174\/astr.2014.87.1.44","volume":"87","author":"KM Kim","year":"2014","unstructured":"Kim, K. M., Bae, B. K. & Lee, S. B. Spontaneous splenic rupture in Plasmodium vivax malaria. Ann. Surg. Treat. Res. 87, 44\u201346 (2014).","journal-title":"Ann. Surg. Treat. Res."},{"key":"2246_CR112","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.262796299","volume":"100","author":"IM Rouzine","year":"2003","unstructured":"Rouzine, I. M. & McKenzie, F. E. Link between immune response and parasite synchronization in malaria. Proc. Natl. Acad. Sci. USA 100, 3473\u20133478 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR113","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00285-010-0381-5","volume":"63","author":"Y Su","year":"2011","unstructured":"Su, Y., Ruan, S. & Wei, J. Periodicity and synchronization in blood-stage malaria infection. J. Math. Biol. 63, 557\u2013574 (2011).","journal-title":"J. Math. Biol."},{"key":"2246_CR114","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0169-4758(89)90261-5","volume":"5","author":"D Kwiatkowski","year":"1989","unstructured":"Kwiatkowski, D. & Greenwood, B. M. Why is malaria fever periodic? A hypothesis. Parasitol. Today 5, 264\u2013266 (1989).","journal-title":"Parasitol. Today"},{"key":"2246_CR115","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.aba4357","volume":"368","author":"LM Smith","year":"2020","unstructured":"Smith, L. M. et al. An intrinsic oscillator drives the blood stage cycle of the malaria parasite Plasmodium falciparum. Science 368, 754\u2013759 (2020).","journal-title":"Science"},{"key":"2246_CR116","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1073\/pnas.89.8.3200","volume":"89","author":"ND Karunaweera","year":"1992","unstructured":"Karunaweera, N. D., Grau, G. E., Gamage, P., Carter, R. & Mendis, K. N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl. Acad. Sci. USA 89, 3200\u20133203 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR117","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1128\/CMR.00027-07","volume":"20","author":"WE Collins","year":"2007","unstructured":"Collins, W. E. & Jeffery, G. M. Plasmodium malariae: parasite and disease. Clin. Microbiol. Rev. 20, 579\u2013592 (2007).","journal-title":"Clin. Microbiol. Rev."},{"key":"2246_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2509-9","volume":"17","author":"NJ White","year":"2018","unstructured":"White, N. J. Anaemia and malaria. Malar. J. 17, 371 (2018).","journal-title":"Malar. J."},{"key":"2246_CR119","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/infdis\/jiu487","volume":"211","author":"DA Lampah","year":"2015","unstructured":"Lampah, D. A. et al. Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia. J. Infect. Dis. 211, 623\u2013634 (2015).","journal-title":"J. Infect. Dis."},{"key":"2246_CR120","volume":"59","author":"GBDJ Silva","year":"2017","unstructured":"Silva, G. B. D. J., Pinto, J. R., Barros, E. J. G., Farias, G. M. N. & Daher, E. F. Kidney involvement in malaria: an update. Rev. Inst. Med. Trop. Sao Paulo 59, e53 (2017).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"2246_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-1008-5","volume":"14","author":"S Nunes-Silva","year":"2015","unstructured":"Nunes-Silva, S. et al. Beninese children with cerebral malaria do not develop humoral immunity against the IT4-VAR19-DC8 PfEMP1 variant linked to EPCR and brain endothelial binding. Malar. J. 14, 493 (2015).","journal-title":"Malar. J."},{"key":"2246_CR122","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pt.2023.11.005","volume":"40","author":"SC Wassmer","year":"2024","unstructured":"Wassmer, S. C., de Koning-Ward, T. F., Grau, G. E. R. & Pai, S. Unravelling mysteries at the perivascular space: a new rationale for cerebral malaria pathogenesis. Trends Parasitol. 40, 28\u201344 (2024).","journal-title":"Trends Parasitol."},{"key":"2246_CR123","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/40888","volume":"388","author":"JA Rowe","year":"1997","unstructured":"Rowe, J. A., Moulds, J. M., Newbold, C. I. & Miller, L. H. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388, 292\u2013295 (1997).","journal-title":"Nature"},{"key":"2246_CR124","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/0140-6736(90)93174-N","volume":"336","author":"J Carlson","year":"1990","unstructured":"Carlson, J. et al. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336, 1457\u20131460 (1990).","journal-title":"Lancet"},{"key":"2246_CR125","doi-asserted-by":"publisher","first-page":"15835","DOI":"10.1073\/pnas.0610485104","volume":"104","author":"J Normark","year":"2007","unstructured":"Normark, J. et al. PfEMP1-DBL1alpha amino acid motifs in severe disease states of Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 104, 15835\u201315840 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR126","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41582-023-00881-4","volume":"19","author":"A Hadjilaou","year":"2023","unstructured":"Hadjilaou, A., Brandi, J., Riehn, M., Friese, M. A. & Jacobs, T. Pathogenetic mechanisms and treatment targets in cerebral malaria. Nat. Rev. Neurol. 19, 688\u2013709 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"2246_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1207-4","volume":"15","author":"KD Wilson","year":"2018","unstructured":"Wilson, K. D. et al. Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria. J. Neuroinflamm. 15, 173 (2018).","journal-title":"J. Neuroinflamm."},{"key":"2246_CR128","doi-asserted-by":"publisher","first-page":"172","DOI":"10.12688\/wellcomeopenres.19166.1","volume":"8","author":"KJ Wilson","year":"2023","unstructured":"Wilson, K. J. et al. Predicting acute and post-recovery outcomes in cerebral malaria and other comas by Optical Coherence Tomography (OCT in CM)\u2014a protocol for an observational cohort study of Malawian children. Wellcome Open Res 8, 172 (2023).","journal-title":"Wellcome Open Res"},{"key":"2246_CR129","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1400116","volume":"372","author":"KB Seydel","year":"2015","unstructured":"Seydel, K. B. et al. Brain swelling and death in children with cerebral malaria. N. Engl. J. Med. 372, 1126\u20131137 (2015).","journal-title":"N. Engl. J. Med."},{"key":"2246_CR130","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/nen.0b013e3181461965","volume":"66","author":"WI Rosenblum","year":"2007","unstructured":"Rosenblum, W. I. Cytotoxic edema: monitoring its magnitude and contribution to brain swelling. J. Neuropathol. Exp. Neurol. 66, 771\u2013778 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2246_CR131","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1172\/JCI133474","volume":"130","author":"BA Riggle","year":"2020","unstructured":"Riggle, B. A. et al. CD8+ T cells target cerebrovasculature in children with cerebral malaria. J. Clin. Investig. 130, 1128\u20131138 (2020).","journal-title":"J. Clin. Investig."},{"key":"2246_CR132","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00193-17","volume":"2","author":"S Mohanty","year":"2017","unstructured":"Mohanty, S. et al. Magnetic resonance imaging of cerebral malaria patients reveals distinct pathogenetic processes in different parts of the brain. mSphere 2, e00193 (2017).","journal-title":"mSphere"},{"key":"2246_CR133","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/cid\/ciad651","volume":"78","author":"C Coughlan","year":"2024","unstructured":"Coughlan, C. et al. Adult cerebral malaria: acute and subacute imaging findings, long-term clinical consequences. Clin. Infect. Dis. 78, 457\u2013460 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR134","doi-asserted-by":"publisher","first-page":"omx011","DOI":"10.1093\/omcr\/omx011","volume":"2017","author":"SR Sudulagunta","year":"2017","unstructured":"Sudulagunta, S. R., Sodalagunta, M. B., Kumbhat, M. & Settikere Nataraju, A. Posterior reversible encephalopathy syndrome (PRES). Oxf. Med. Case Rep. 2017, omx011 (2017).","journal-title":"Oxf. Med. Case Rep."},{"key":"2246_CR135","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ccell.2015.09.003","volume":"28","author":"A Salanti","year":"2015","unstructured":"Salanti, A. et al. Targeting human cancer by a glycosaminoglycan binding malaria protein. Cancer Cell 28, 500\u2013514 (2015).","journal-title":"Cancer Cell"},{"key":"2246_CR136","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1073\/pnas.1000951107","volume":"107","author":"A Srivastava","year":"2010","unstructured":"Srivastava, A. et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc. Natl. Acad. Sci. USA 107, 4884\u20134889 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR137","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1126\/science.272.5267.1502","volume":"272","author":"M Fried","year":"1996","unstructured":"Fried, M. & Duffy, P. E. Adherence of Plasmodium falciparum to Chondroitin sulfate A in the human placenta. Science 272, 1502\u20131504 (1996).","journal-title":"Science"},{"key":"2246_CR138","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.molmed.2016.08.005","volume":"22","author":"PM Odorizzi","year":"2016","unstructured":"Odorizzi, P. M. & Feeney, M. E. Impact of in utero exposure to malaria on fetal T cell immunity. Trends Mol. Med. 22, 877\u2013888 (2016).","journal-title":"Trends Mol. Med."},{"key":"2246_CR139","doi-asserted-by":"publisher","first-page":"1229735","DOI":"10.3389\/fitd.2023.1229735","volume":"4","author":"AD Berhe","year":"2023","unstructured":"Berhe, A. D. & Doritchamou, J. Y. Malaria in pregnancy: adverse pregnancy outcomes and the future of prevention. Front. Trop. Dis. 4, 1229735 (2023).","journal-title":"Front. Trop. Dis."},{"key":"2246_CR140","doi-asserted-by":"publisher","first-page":"e1000221","DOI":"10.1371\/journal.pmed.1000221","volume":"7","author":"S Dellicour","year":"2010","unstructured":"Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W. & ter Kuile, F. O. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 7, e1000221 (2010).","journal-title":"PLoS Med."},{"key":"2246_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04816-8","volume":"23","author":"SLS Kamga","year":"2024","unstructured":"Kamga, S. L. S. et al. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross-sectional study. Malar. J. 23, 6 (2024).","journal-title":"Malar. J."},{"key":"2246_CR142","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41564-020-00858-9","volume":"6","author":"R Ma","year":"2021","unstructured":"Ma, R. et al. Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA. Nat. Microbiol. 6, 380\u2013391 (2021).","journal-title":"Nat. Microbiol."},{"key":"2246_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23254-1","volume":"12","author":"K Wang","year":"2021","unstructured":"Wang, K. et al. Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding. Nat. Commun. 12, 2956 (2021).","journal-title":"Nat. Commun."},{"key":"2246_CR144","doi-asserted-by":"publisher","first-page":"e3000308","DOI":"10.1371\/journal.pbio.3000308","volume":"17","author":"D Dorin-Semblat","year":"2019","unstructured":"Dorin-Semblat, D. et al. Phosphorylation of the VAR2CSA extracellular region is associated with enhanced adhesive properties to the placental receptor CSA. PLoS Biol. 17, e3000308 (2019).","journal-title":"PLoS Biol."},{"key":"2246_CR145","first-page":"83","volume":"22","author":"F Elzein","year":"2017","unstructured":"Elzein, F. et al. Pulmonary manifestation of Plasmodium falciparum malaria: case reports and review of the literature. Respir. Med. Case Rep. 22, 83\u201386 (2017).","journal-title":"Respir. Med. Case Rep."},{"key":"2246_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2251-3","volume":"17","author":"L Vandermosten","year":"2018","unstructured":"Vandermosten, L. et al. Experimental malaria-associated acute respiratory distress syndrome is dependent on the parasite-host combination and coincides with normocyte invasion. Malar. J. 17, 102 (2018).","journal-title":"Malar. J."},{"key":"2246_CR147","doi-asserted-by":"crossref","unstructured":"Hoffmeister, B. Respiratory distress complicating falciparum malaria imported to berlin, germany: incidence, burden, and risk factors. Microorganisms 11 (2023).","DOI":"10.3390\/microorganisms11061579"},{"key":"2246_CR148","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.pt.2013.04.006","volume":"29","author":"PE Van den Steen","year":"2013","unstructured":"Van den Steen, P. E. et al. Pathogenesis of malaria-associated acute respiratory distress syndrome. Trends Parasitol. 29, 346\u2013358 (2013).","journal-title":"Trends Parasitol."},{"key":"2246_CR149","first-page":"385","volume":"119","author":"GG MacPherson","year":"1985","unstructured":"MacPherson, G. G., Warrell, M. J., White, N. J., Looareesuwan, S. & Warrell, D. A. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119, 385\u2013401 (1985).","journal-title":"Am. J. Pathol."},{"key":"2246_CR150","doi-asserted-by":"publisher","first-page":"e0181674","DOI":"10.1371\/journal.pone.0181674","volume":"12","author":"S Maknitikul","year":"2017","unstructured":"Maknitikul, S., Luplertlop, N., Grau, G. E. R. & Ampawong, S. Dysregulation of pulmonary endothelial protein C receptor and thrombomodulin in severe falciparum malaria-associated ARDS relevant to hemozoin. PLoS One 12, e0181674 (2017).","journal-title":"PLoS One"},{"key":"2246_CR151","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2165\/00151829-200605060-00007","volume":"5","author":"WR Taylor","year":"2006","unstructured":"Taylor, W. R., Ca\u00f1on, V. & White, N. J. Pulmonary manifestations of malaria : recognition and management. Treat. Respir. Med. 5, 419\u2013428 (2006).","journal-title":"Treat. Respir. Med."},{"key":"2246_CR152","doi-asserted-by":"publisher","first-page":"e0235437","DOI":"10.1371\/journal.pone.0235437","volume":"15","author":"L Gra\u00e7a","year":"2020","unstructured":"Gra\u00e7a, L. et al. Descriptive Acute Respiratory Distress Syndrome (ARDS) in adults with imported severe Plasmodium falciparum malaria: a 10 year-study in a Portuguese tertiary care hospital. PLoS One 15, e0235437 (2020).","journal-title":"PLoS One"},{"key":"2246_CR153","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","volume":"364","author":"K Maitland","year":"2011","unstructured":"Maitland, K. et al. Mortality after fluid bolus in African children with severe infection. N. Engl. J. Med. 364, 2483\u20132495 (2011).","journal-title":"N. Engl. J. Med."},{"key":"2246_CR154","first-page":"9","volume":"2","author":"SA Zaki","year":"2011","unstructured":"Zaki, S. A. & Shanbag, P. Atypical manifestations of malaria. Res Rep. Trop. Med. 2, 9\u201322 (2011).","journal-title":"Res Rep. Trop. Med."},{"key":"2246_CR155","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1378\/chest.11-2655","volume":"142","author":"WRJ Taylor","year":"2012","unstructured":"Taylor, W. R. J., Hanson, J., Turner, G. D. H., White, N. J. & Dondorp, A. M. Respiratory manifestations of malaria. Chest 142, 492\u2013505 (2012).","journal-title":"Chest"},{"key":"2246_CR156","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pathmechdis-012419-032640","volume":"15","author":"CA Moxon","year":"2020","unstructured":"Moxon, C. A., Gibbins, M. P., McGuinness, D., Milner, D. A. Jr & Marti, M. New Insights into malaria pathogenesis. Annu. Rev. Pathol. 15, 315\u2013343 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"2246_CR157","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.pt.2020.12.008","volume":"37","author":"M Bernabeu","year":"2021","unstructured":"Bernabeu, M., Howard, C., Zheng, Y. & Smith, J. D. Bioengineered 3D microvessels for investigating Plasmodium falciparum pathogenesis. Trends Parasitol. 37, 401\u2013413 (2021).","journal-title":"Trends Parasitol."},{"key":"2246_CR158","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1128\/IAI.73.11.7736-7746.2005","volume":"73","author":"F Pettersson","year":"2005","unstructured":"Pettersson, F. et al. Whole-body imaging of sequestration of Plasmodium falciparum in the rat. Infect. Immun. 73, 7736\u20137746 (2005).","journal-title":"Infect. Immun."},{"key":"2246_CR159","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1371\/journal.ppat.0020100","volume":"2","author":"AM Vogt","year":"2006","unstructured":"Vogt, A. M. et al. Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathog. 2, e100 (2006).","journal-title":"PLoS Pathog."},{"key":"2246_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12017-8","volume":"10","author":"C Claser","year":"2019","unstructured":"Claser, C. et al. Lung endothelial cell antigen cross-presentation to CD8+T cells drives malaria-associated lung injury. Nat. Commun. 10, 4241 (2019).","journal-title":"Nat. Commun."},{"key":"2246_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45210-5","volume":"15","author":"X Du","year":"2024","unstructured":"Du, X. et al. PRL2 regulates neutrophil extracellular trap formation which contributes to severe malaria and acute lung injury. Nat. Commun. 15, 881 (2024).","journal-title":"Nat. Commun."},{"key":"2246_CR162","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41579-019-0306-2","volume":"18","author":"K Venugopal","year":"2020","unstructured":"Venugopal, K., Hentzschel, F., Valki\u016bnas, G. & Marti, M. Plasmodium asexual growth and sexual development in the haematopoietic niche of the host. Nat. Rev. Microbiol 18, 177\u2013189 (2020).","journal-title":"Nat. Rev. Microbiol"},{"key":"2246_CR163","doi-asserted-by":"publisher","first-page":"877907","DOI":"10.3389\/fcimb.2022.877907","volume":"12","author":"M Dash","year":"2022","unstructured":"Dash, M., Sachdeva, S., Bansal, A. & Sinha, A. Gametogenesis in Plasmodium: delving deeper to connect the dots. Front. Cell Infect. Microbiol 12, 877907 (2022).","journal-title":"Front. Cell Infect. Microbiol"},{"key":"2246_CR164","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature12920","volume":"507","author":"BF Kafsack","year":"2014","unstructured":"Kafsack, B. F. et al. A transcriptional switch underlies commitment to sexual development in malaria parasites. Nature 507, 248\u2013252 (2014).","journal-title":"Nature"},{"key":"2246_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15026-0","volume":"11","author":"GA Josling","year":"2020","unstructured":"Josling, G. A. et al. Dissecting the role of PfAP2-G in malaria gametocytogenesis. Nat. Commun. 11, 1503 (2020).","journal-title":"Nat. Commun."},{"key":"2246_CR166","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz5057","volume":"6","author":"O Llor\u00e0-Batlle","year":"2020","unstructured":"Llor\u00e0-Batlle, O. et al. Conditional expression of PfAP2-G for controlled massive sexual conversion in Plasmodium falciparum. Sci. Adv. 6, eaaz5057 (2020).","journal-title":"Sci. Adv."},{"key":"2246_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.631444","volume":"11","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. PfAP2-G2 is associated to production and maturation of gametocytes in Plasmodium falciparum via regulating the expression of PfMDV-1. Front. Microbiol. 11, 631444 (2020).","journal-title":"Front. Microbiol."},{"key":"2246_CR168","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051660","volume":"22","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Plasmodium transcription repressor AP2-O3 regulates sex-specific identity of gene expression in female gametocytes. EMBO Rep. 22, e51660 (2021).","journal-title":"EMBO Rep."},{"key":"2246_CR169","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/mmi.14334","volume":"113","author":"M Yuda","year":"2020","unstructured":"Yuda, M., Kaneko, I., Iwanaga, S., Murata, Y. & Kato, T. Female-specific gene regulation in malaria parasites by an AP2-family transcription factor. Mol. Microbiol. 113, 40\u201351 (2020).","journal-title":"Mol. Microbiol."},{"key":"2246_CR170","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijpara.2017.03.002","volume":"47","author":"DP Bechtsi","year":"2017","unstructured":"Bechtsi, D. P. & Waters, A. P. Genomics and epigenetics of sexual commitment in Plasmodium. Int. J. Parasitol. 47, 425\u2013434 (2017).","journal-title":"Int. J. Parasitol."},{"key":"2246_CR171","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1021\/acs.jproteome.2c00108","volume":"21","author":"S Shrestha","year":"2022","unstructured":"Shrestha, S. et al. Distinct histone post-translational modifications during Plasmodium falciparum Gametocyte development. J. Proteome Res. 21, 1857\u20131867 (2022).","journal-title":"J. Proteome Res."},{"key":"2246_CR172","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12915-023-01568-4","volume":"21","author":"MD Jeninga","year":"2023","unstructured":"Jeninga, M. D. et al. Plasmodium falciparum gametocytes display global chromatin remodelling during sexual differentiation. BMC Biol. 21, 65 (2023).","journal-title":"BMC Biol."},{"key":"2246_CR173","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010890","volume":"19","author":"T Nishi","year":"2023","unstructured":"Nishi, T., Kaneko, I., Iwanaga, S. & Yuda, M. PbAP2-FG2 and PbAP2R-2 function together as a transcriptional repressor complex essential for Plasmodium female development. PLoS Pathog. 19, e1010890 (2023).","journal-title":"PLoS Pathog."},{"key":"2246_CR174","doi-asserted-by":"publisher","first-page":"e1004905","DOI":"10.1371\/journal.ppat.1004905","volume":"11","author":"I Kaneko","year":"2015","unstructured":"Kaneko, I., Iwanaga, S., Kato, T., Kobayashi, I. & Yuda, M. Genome-wide identification of the target genes of AP2-O, a Plasmodium AP2-family transcription factor. PLoS Pathog. 11, e1004905 (2015).","journal-title":"PLoS Pathog."},{"key":"2246_CR175","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1365-2958.2009.06609.x","volume":"71","author":"M Yuda","year":"2009","unstructured":"Yuda, M. et al. Identification of a transcription factor in the mosquito-invasive stage of malaria parasites. Mol. Microbiol. 71, 1402\u20131414 (2009).","journal-title":"Mol. Microbiol."},{"key":"2246_CR176","doi-asserted-by":"publisher","first-page":"e1010510","DOI":"10.1371\/journal.ppat.1010510","volume":"18","author":"T Nishi","year":"2022","unstructured":"Nishi, T., Kaneko, I., Iwanaga, S. & Yuda, M. Identification of a novel AP2 transcription factor in zygotes with an essential role in Plasmodium ookinete development. PLoS Pathog. 18, e1010510 (2022).","journal-title":"PLoS Pathog."},{"key":"2246_CR177","doi-asserted-by":"crossref","unstructured":"Frischknecht, F. & Matuschewski, K. Plasmodium sporozoite biology. Cold Spring Harb. Perspect. Med. 7 (2017).","DOI":"10.1101\/cshperspect.a025478"},{"key":"2246_CR178","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.chom.2016.12.003","volume":"21","author":"K Modrzynska","year":"2017","unstructured":"Modrzynska, K. et al. A knockout screen of ApiAP2 genes reveals networks of interacting transcriptional regulators controlling the plasmodium life cycle. Cell Host Microbe 21, 11\u201322 (2017).","journal-title":"Cell Host Microbe"},{"key":"2246_CR179","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1365-2958.2009.07005.x","volume":"75","author":"M Yuda","year":"2010","unstructured":"Yuda, M., Iwanaga, S., Shigenobu, S., Kato, T. & Kaneko, I. Transcription factor AP2-Sp and its target genes in malarial sporozoites. Mol. Microbiol. 75, 854\u2013863 (2010).","journal-title":"Mol. Microbiol."},{"key":"2246_CR180","doi-asserted-by":"publisher","first-page":"e1000086","DOI":"10.1371\/journal.ppat.1000086","volume":"4","author":"O Silvie","year":"2008","unstructured":"Silvie, O., Goetz, K. & Matuschewski, K. A sporozoite asparagine-rich protein controls initiation of plasmodium liver stage development. PLoS Pathog. 4, e1000086 (2008).","journal-title":"PLoS Pathog."},{"key":"2246_CR181","doi-asserted-by":"crossref","unstructured":"Yuda, M., Kaneko, I., Murata, Y., Iwanaga, S. & Nishi, T. Targetome analysis of malaria sporozoite transcription factor AP2-Sp reveals its role as a master regulator. mBio 14 (2023).","DOI":"10.1128\/mbio.02516-22"},{"key":"2246_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1169","volume":"2","author":"C Gr\u00fcring","year":"2011","unstructured":"Gr\u00fcring, C. et al. Development and host cell modifications of Plasmodium falciparum blood stages in four dimensions. Nat. Commun. 2, 165 (2011).","journal-title":"Nat. Commun."},{"key":"2246_CR183","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1086\/380468","volume":"189","author":"R Suwanarusk","year":"2004","unstructured":"Suwanarusk, R. et al. The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. J. Infect. Dis. 189, 190\u2013194 (2004).","journal-title":"J. Infect. Dis."},{"key":"2246_CR184","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03510-23","volume":"15","author":"K Zheng","year":"2024","unstructured":"Zheng, K. et al. Plasmodium falciparum selectively degrades \u03b1-spectrin of infected erythrocytes after invasion. mBio 15, e0351023 (2024).","journal-title":"mBio"},{"key":"2246_CR185","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.RA120.002375","volume":"205","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Protein modification characteristics of the malaria parasite Plasmodium falciparum and the infected erythrocytes. Mol. Cell Proteom. 205, 100001 (2021).","journal-title":"Mol. Cell Proteom."},{"key":"2246_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0771-5","volume":"16","author":"SS Vembar","year":"2015","unstructured":"Vembar, S. S., Macpherson, C. R., Sismeiro, O., Copp\u00e9e, J. Y. & Scherf, A. The PfAlba1 RNA-binding protein is an important regulator of translational timing in Plasmodium falciparum blood stages. Genome Biol. 16, 212 (2015).","journal-title":"Genome Biol."},{"key":"2246_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0406-2","volume":"15","author":"S Das","year":"2017","unstructured":"Das, S., Lemgruber, L., Tay, C. L., Baum, J. & Meissner, M. Multiple essential functions of Plasmodium falciparum actin-1 during malaria blood-stage development. BMC Biol. 15, 70 (2017).","journal-title":"BMC Biol."},{"key":"2246_CR188","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49030","volume":"8","author":"JF Stortz","year":"2019","unstructured":"Stortz, J. F. et al. Formin-2 drives polymerisation of actin filaments enabling segregation of apicoplasts and cytokinesis in Plasmodium falciparum. ELife 8, e49030 (2019).","journal-title":"ELife"},{"key":"2246_CR189","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/mBio.00605-17","volume":"8","author":"JA Robbins","year":"2017","unstructured":"Robbins, J. A., Absalon, S., Streva, V. A. & Dvorin, J. D. The malaria parasite cyclin H homolog Pfcyc1 is required for efficient cytokinesis in blood-stage Plasmodium falciparum. mBio 8, 3 (2017).","journal-title":"mBio"},{"key":"2246_CR190","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.ppat.1011157","volume":"19","author":"Y Vo\u00df","year":"2023","unstructured":"Vo\u00df, Y., Klaus, S., Guizetti, J. & Ganter, M. Plasmodium schizogony, a chronology of the parasite\u2019s cell cycle in the blood stage. PLoS Pathog. 19, 3 (2023).","journal-title":"PLoS Pathog."},{"key":"2246_CR191","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.chom.2017.05.006","volume":"21","author":"JM Santos","year":"2017","unstructured":"Santos, J. M. et al. Red blood cell invasion by the malaria parasite is coordinated by the PfAP2-I transcription factor. Cell Host Microbe 21, 731\u2013741 (2017).","journal-title":"Cell Host Microbe"},{"key":"2246_CR192","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/nar\/gkac176","volume":"50","author":"X Shang","year":"2022","unstructured":"Shang, X. et al. Genome-wide landscape of ApiAP2 transcription factors reveals a heterochromatin-associated regulatory network during Plasmodium falciparum blood-stage development. Nucleic Acids Res. 50, 3413\u20133431 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2246_CR193","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/s41564-023-01497-6","volume":"8","author":"AK Subudhi","year":"2023","unstructured":"Subudhi, A. K. et al. DNA-binding protein PfAP2-P regulates parasite pathogenesis during malaria parasite blood stages. Nat. Microbiol. 8, 2154\u20132169 (2023).","journal-title":"Nat. Microbiol."},{"key":"2246_CR194","doi-asserted-by":"publisher","first-page":"e3001408","DOI":"10.1371\/journal.pbio.3001408","volume":"19","author":"AC Schlott","year":"2021","unstructured":"Schlott, A. C. et al. Inhibition of protein N-myristoylation blocks Plasmodium falciparum intraerythrocytic development, egress and invasion. PLoS Biol. 19, e3001408 (2021).","journal-title":"PLoS Biol."},{"key":"2246_CR195","unstructured":"Liu, Y. et al. An inner membrane complex protein IMC1g in Plasmodium berghei is involved in asexual stage schizogony and parasite transmission. mBio e02652\u201302624 (2023)."},{"key":"2246_CR196","first-page":"5","volume":"14","author":"K Cepeda Diaz Ana","year":"2023","unstructured":"Cepeda Diaz Ana, K., Rudlaff Rachel, M., Farringer, M. & Dvorin Jeffrey, D. Essential function of alveolin PfIMC1g in the Plasmodium falciparum asexual blood stage. mBio 14, 5 (2023).","journal-title":"mBio"},{"key":"2246_CR197","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114442118","volume":"118","author":"K Yahata","year":"2021","unstructured":"Yahata, K. et al. Gliding motility of Plasmodium merozoites. Proc. Natl. Acad. Sci. USA 118, e2114442118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR198","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijpara.2008.09.007","volume":"39","author":"PR Gilson","year":"2009","unstructured":"Gilson, P. R. & Crabb, B. S. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int. J. Parasitol. 39, 91\u201396 (2009).","journal-title":"Int. J. Parasitol."},{"key":"2246_CR199","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/femsre\/fuw001","volume":"40","author":"JG Beeson","year":"2016","unstructured":"Beeson, J. G. et al. Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. FEMS Microbiol. Rev. 40, 343\u2013372 (2016).","journal-title":"FEMS Microbiol. Rev."},{"key":"2246_CR200","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61516","volume":"10","author":"B Shakya","year":"2021","unstructured":"Shakya, B., Patel, S. D., Tani, Y. & Egan, E. Erythrocyte CD55 mediates the internalization of Plasmodium falciparum parasites. ELife 10, e61516 (2021).","journal-title":"ELife"},{"key":"2246_CR201","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1182\/blood.2023022781","volume":"142","author":"N Mohandas","year":"2023","unstructured":"Mohandas, N. & Blanc, L. Parasite hijacks red cell membrane proteins. Blood 142, 1942\u20131944 (2023).","journal-title":"Blood"},{"key":"2246_CR202","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1074\/mcp.M600035-MCP200","volume":"5","author":"PR Gilson","year":"2006","unstructured":"Gilson, P. R. et al. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol. Cell Proteom. 5, 1286\u20131299 (2006).","journal-title":"Mol. Cell Proteom."},{"key":"2246_CR203","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.peptides.2006.02.001","volume":"27","author":"R L\u00f3pez","year":"2006","unstructured":"L\u00f3pez, R. et al. Plasmodium falciparum merozoite surface protein 6 (MSP-6) derived peptides bind erythrocytes and partially inhibit parasite invasion. Peptides 27, 1685\u20131692 (2006).","journal-title":"Peptides"},{"key":"2246_CR204","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0166-6851(01)00433-9","volume":"120","author":"E Vargas-Serrato","year":"2002","unstructured":"Vargas-Serrato, E. et al. Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101\/ABRA of P. falciparum. Mol. Biochem. Parasitol. 120, 41\u201352 (2002).","journal-title":"Mol. Biochem. Parasitol."},{"key":"2246_CR205","doi-asserted-by":"publisher","first-page":"25655","DOI":"10.1074\/jbc.M114.586495","volume":"289","author":"CS Lin","year":"2014","unstructured":"Lin, C. S. et al. The merozoite surface protein 1 complex is a platform for binding to human erythrocytes by Plasmodium falciparum. J. Biol. Chem. 289, 25655\u201325669 (2014).","journal-title":"J. Biol. Chem."},{"key":"2246_CR206","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1182\/blood-2014-11-611707","volume":"125","author":"MR Baldwin","year":"2015","unstructured":"Baldwin, M. R., Li, X., Hanada, T., Liu, S. C. & Chishti, A. H. Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells. Blood 125, 2704\u20132711 (2015).","journal-title":"Blood"},{"key":"2246_CR207","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1182\/blood-2009-09-243725","volume":"115","author":"MJ Boyle","year":"2010","unstructured":"Boyle, M. J., Richards, J. S., Gilson, P. R., Chai, W. & Beeson, J. G. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood 115, 4559\u20134568 (2010).","journal-title":"Blood"},{"key":"2246_CR208","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg0465","volume":"7","author":"PM Dijkman","year":"2021","unstructured":"Dijkman, P. M. et al. Structure of the merozoite surface protein 1 from Plasmodium falciparum. Sci. Adv. 7, eabg0465 (2021).","journal-title":"Sci. Adv."},{"key":"2246_CR209","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.chom.2015.09.007","volume":"18","author":"S Das","year":"2015","unstructured":"Das, S. et al. Processing of Plasmodium falciparum merozoite surface protein MSP1 activates a spectrin-binding function enabling parasite Egress from RBCs. Cell Host Microbe 18, 433\u2013444 (2015).","journal-title":"Cell Host Microbe"},{"key":"2246_CR210","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0166-6851(92)90228-C","volume":"50","author":"MJ Blackman","year":"1992","unstructured":"Blackman, M. J. & Holder, A. A. Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. Mol. Biochem. Parasitol. 50, 307\u2013315 (1992).","journal-title":"Mol. Biochem. Parasitol."},{"key":"2246_CR211","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1074\/jbc.M115.698282","volume":"291","author":"CS Lin","year":"2016","unstructured":"Lin, C. S. et al. Multiple Plasmodium falciparum merozoite surface protein 1 complexes mediate merozoite binding to human erythrocytes. J. Biol. Chem. 291, 7703\u20137715 (2016).","journal-title":"J. Biol. Chem."},{"key":"2246_CR212","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.ppat.0010029","volume":"1","author":"PK Harris","year":"2005","unstructured":"Harris, P. K. et al. Molecular identification of a malaria merozoite surface sheddase. PLoS Pathog. 1, e29 (2005).","journal-title":"PLoS Pathog."},{"key":"2246_CR213","doi-asserted-by":"publisher","first-page":"e00673","DOI":"10.1128\/mbio.00673-23","volume":"14","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee, S., Nasamu, A. S., Rubiano, K. C. & Goldberg, D. E. Activation of the Plasmodium Egress effector subtilisin-like protease 1 is mediated by Plasmepsin X destruction of the prodomain. mBio 14, e00673\u201300623 (2023).","journal-title":"mBio"},{"key":"2246_CR214","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61121","volume":"9","author":"CR Collins","year":"2020","unstructured":"Collins, C. R. et al. The malaria parasite sheddase SUB2 governs host red blood cell membrane sealing at invasion. ELife 9, e61121 (2020).","journal-title":"ELife"},{"key":"2246_CR215","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1021\/pr400038j","volume":"12","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Proteomic Analysis of Plasmodium falciparum schizonts reveals heparin-binding merozoite proteins. J. Proteome Res. 12, 2185\u20132193 (2013).","journal-title":"J. Proteome Res."},{"key":"2246_CR216","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1182\/blood-2002-07-2016","volume":"101","author":"AM Vogt","year":"2003","unstructured":"Vogt, A. M. et al. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 101, 2405\u20132411 (2003).","journal-title":"Blood"},{"key":"2246_CR217","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.chom.2007.10.002","volume":"2","author":"A Coppi","year":"2007","unstructured":"Coppi, A. et al. Heparan sulfate proteoglycans provide a signal to plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe 2, 316\u2013327 (2007).","journal-title":"Cell Host Microbe"},{"key":"2246_CR218","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13071-023-05896-w","volume":"16","author":"J Gao","year":"2023","unstructured":"Gao, J. et al. A heparin-binding protein of Plasmodium berghei is associated with merozoite invasion of erythrocytes. Parasites Vectors 16, 277 (2023).","journal-title":"Parasites Vectors"},{"key":"2246_CR219","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1021\/acsami.0c20070","volume":"13","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Enhanced antimalarial efficacy obtained by targeted delivery of artemisinin in heparin-coated magnetic hollow mesoporous nanoparticles. ACS Appl. Mater. Interfaces 13, 287\u2013297 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2246_CR220","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molbiopara.2009.03.012","volume":"166","author":"CG Adda","year":"2009","unstructured":"Adda, C. G. et al. Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils. Mol. Biochem. Parasitol. 166, 159\u2013171 (2009).","journal-title":"Mol. Biochem. Parasitol."},{"key":"2246_CR221","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/IAI.01021-10","volume":"79","author":"S Lopaticki","year":"2011","unstructured":"Lopaticki, S. et al. Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infect. Immun. 79, 1107\u20131117 (2011).","journal-title":"Infect. Immun."},{"key":"2246_CR222","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1073\/pnas.0730883100","volume":"100","author":"MT Duraisingh","year":"2003","unstructured":"Duraisingh, M. T., Maier, A. G., Triglia, T. & Cowman, A. F. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc. Natl Acad. Sci. USA 100, 4796\u20134801 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2246_CR223","doi-asserted-by":"publisher","first-page":"e1003943","DOI":"10.1371\/journal.ppat.1003943","volume":"10","author":"GJ Wright","year":"2014","unstructured":"Wright, G. J. & Rayner, J. C. Plasmodium falciparum erythrocyte invasion: combining function with immune evasion. PLoS Pathog. 10, e1003943 (2014).","journal-title":"PLoS Pathog."},{"key":"2246_CR224","doi-asserted-by":"publisher","first-page":"e1000746","DOI":"10.1371\/journal.ppat.1000746","volume":"6","author":"S Singh","year":"2010","unstructured":"Singh, S., Alam, M. M., Pal-Bhowmick, I., Brzostowski, J. A. & Chitnis, C. E. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog. 6, e1000746 (2010).","journal-title":"PLoS Pathog."},{"key":"2246_CR225","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cell.2005.05.033","volume":"122","author":"NH Tolia","year":"2005","unstructured":"Tolia, N. H., Enemark, E. J., Sim, B. K. & Joshua-Tor, L. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 122, 183\u2013193 (2005).","journal-title":"Cell"},{"key":"2246_CR226","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43224","volume":"7","author":"MM Paing","year":"2018","unstructured":"Paing, M. M. et al. Shed EBA-175 mediates red blood cell clustering that enhances malaria parasite growth and enables immune evasion. ELife 7, e43224 (2018).","journal-title":"ELife"},{"key":"2246_CR227","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1182\/blood.2023020831","volume":"142","author":"B Baro","year":"2023","unstructured":"Baro, B. et al. Plasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion. Blood 142, 2016\u20132028 (2023).","journal-title":"Blood"},{"key":"2246_CR228","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0166-6851(94)90134-1","volume":"64","author":"SA Dolan","year":"1994","unstructured":"Dolan, S. A. et al. Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol. Biochem. Parasitol. 64, 55\u201363 (1994).","journal-title":"Mol. Biochem. Parasitol."},{"key":"2246_CR229","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1073\/pnas.0307318101","volume":"101","author":"DCG Mayer","year":"2004","unstructured":"Mayer, D. C. G. et al. Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL\/EBA-181 alters its receptor specificity. Proc. Natl. Acad. Sci. USA 101, 2518\u20132523 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR230","doi-asserted-by":"publisher","first-page":"e0115437","DOI":"10.1371\/journal.pone.0115437","volume":"10","author":"J Rydzak","year":"2015","unstructured":"Rydzak, J. et al. The baculovirus-expressed binding region of Plasmodium falciparum EBA-140 ligand and its glycophorin C binding specificity. PLoS One 10, e0115437 (2015).","journal-title":"PLoS One"},{"key":"2246_CR231","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12294-3","volume":"10","author":"WR Proto","year":"2019","unstructured":"Proto, W. R. et al. Adaptation of Plasmodium falciparum to humans involved the loss of an ape-specific erythrocyte invasion ligand. Nat. Commun. 10, 4512 (2019).","journal-title":"Nat. Commun."},{"key":"2246_CR232","doi-asserted-by":"publisher","first-page":"e17102","DOI":"10.1371\/journal.pone.0017102","volume":"6","author":"T Sahar","year":"2011","unstructured":"Sahar, T. et al. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS One 6, e17102 (2011).","journal-title":"PLoS One"},{"key":"2246_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58300-3","volume":"10","author":"Y Aniweh","year":"2020","unstructured":"Aniweh, Y. et al. Analysis of Plasmodium falciparum Rh2b deletion polymorphism across different transmission areas. Sci. Rep. 10, 1498 (2020).","journal-title":"Sci. Rep."},{"key":"2246_CR234","doi-asserted-by":"publisher","first-page":"e1001276","DOI":"10.1371\/journal.ppat.1001276","volume":"7","author":"M Lamarque","year":"2011","unstructured":"Lamarque, M. et al. The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites. PLoS Pathog. 7, e1001276 (2011).","journal-title":"PLoS Pathog."},{"key":"2246_CR235","doi-asserted-by":"publisher","first-page":"e1010643","DOI":"10.1371\/journal.ppat.1010643","volume":"18","author":"P Fernandes","year":"2022","unstructured":"Fernandes, P. et al. The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts. PLoS Pathog. 18, e1010643 (2022).","journal-title":"PLoS Pathog."},{"key":"2246_CR236","doi-asserted-by":"crossref","unstructured":"Krishnamurthy, S. et al. Not a simple tether: binding of Toxoplasma gondii AMA1 to RON2 during invasion protects AMA1 from rhomboid-mediated clvikeavage and leads to dephosphorylation of its Cytosolic Tail. mBio 7 (2016).","DOI":"10.1128\/mBio.00754-16"},{"key":"2246_CR237","doi-asserted-by":"crossref","unstructured":"Weiss, G. E. et al. Revealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytes. PLoS Pathog. 11 (2015).","DOI":"10.1371\/journal.ppat.1004670"},{"key":"2246_CR238","doi-asserted-by":"crossref","unstructured":"Richard, D. et al. Identification of Rhoptry Trafficking Determinants and Evidence for a Novel Sorting Mechanism in the Malaria Parasite Plasmodium falciparum. PLoS Pathog. 5 (2009).","DOI":"10.1371\/journal.ppat.1000328"},{"key":"2246_CR239","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03447-7","volume":"19","author":"NK Mita-Mendoza","year":"2020","unstructured":"Mita-Mendoza, N. K. et al. Dimethyl fumarate reduces TNF and Plasmodium falciparum-induced brain endothelium activation in vitro. Malar. J. 19, 376 (2020).","journal-title":"Malar. J."},{"key":"2246_CR240","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nm1351","volume":"12","author":"U Fiedler","year":"2006","unstructured":"Fiedler, U. et al. Angiopoietin-2 sensitizes endothelial cells to TNF-\u03b1 and has a crucial role in the induction of inflammation. Nat. Med. 12, 235\u2013239 (2006).","journal-title":"Nat. Med."},{"key":"2246_CR241","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.actatropica.2007.02.011","volume":"102","author":"VHM Tchinda","year":"2007","unstructured":"Tchinda, V. H. M. et al. Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-\u03b1. Acta Trop. 102, 20\u201328 (2007).","journal-title":"Acta Trop."},{"key":"2246_CR242","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206327119","volume":"119","author":"TF Pais","year":"2022","unstructured":"Pais, T. F. et al. Brain endothelial STING1 activation by Plasmodium-sequestered heme promotes cerebral malaria via type I IFN response. Proc. Natl. Acad. Sci. USA 119, e2206327119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR243","doi-asserted-by":"publisher","first-page":"19465","DOI":"10.1073\/pnas.2006492117","volume":"117","author":"X He","year":"2020","unstructured":"He, X. et al. RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology. Proc. Natl. Acad. Sci. USA 117, 19465\u201319474 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR244","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1365-3024.2008.01053.x","volume":"30","author":"E Belnoue","year":"2008","unstructured":"Belnoue, E. et al. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 30, 544\u2013553 (2008).","journal-title":"Parasite Immunol."},{"key":"2246_CR245","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/CMR.13.3.439","volume":"13","author":"Q Chen","year":"2000","unstructured":"Chen, Q., Schlichtherle, M. & Wahlgren, M. Molecular aspects of severe malaria. Clin. Microbiol. Rev. 13, 439\u2013450 (2000).","journal-title":"Clin. Microbiol. Rev."},{"key":"2246_CR246","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03114-7","volume":"21","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Neurons upregulate PD-L1 via IFN\/STAT1\/IRF1 to alleviate damage by CD8+ T cells in cerebral malaria. J. Neuroinflamm. 21, 119 (2024).","journal-title":"J. Neuroinflamm."},{"key":"2246_CR247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.192.1.1","volume":"192","author":"Q Chen","year":"2000","unstructured":"Chen, Q. et al. The Semiconserved Head Structure of Plasmodium falciparum Erythrocyte Membrane Protein 1 Mediates Binding to Multiple Independent Host Receptors. J. Exp. Med. 192, 1\u201310 (2000).","journal-title":"J. Exp. Med."},{"key":"2246_CR248","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1073\/pnas.040545897","volume":"97","author":"JD Smith","year":"2000","unstructured":"Smith, J. D. et al. Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. Proc. Natl. Acad. Sci. USA 97, 1766\u20131771 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR249","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4269\/ajtmh.14-0841","volume":"93","author":"SC Wassmer","year":"2015","unstructured":"Wassmer, S. C. et al. Investigating the pathogenesis of severe malaria: a multidisciplinary and cross-geographical approach. Am. J. Trop. Med. Hyg. 93, 42\u201356 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2246_CR250","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/imr.12807","volume":"293","author":"AR Jensen","year":"2020","unstructured":"Jensen, A. R., Adams, Y. & Hviid, L. Cerebral Plasmodium falciparum malaria: the role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it. Immunol. Rev. 293, 230\u2013252 (2020).","journal-title":"Immunol. Rev."},{"key":"2246_CR251","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/415673a","volume":"415","author":"LH Miller","year":"2002","unstructured":"Miller, L. H., Baruch, D. I., Marsh, K. & Doumbo, O. K. The pathogenic basis of malaria. Nature 415, 673\u2013679 (2002).","journal-title":"Nature"},{"key":"2246_CR252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-10-17","volume":"10","author":"L Albrecht","year":"2011","unstructured":"Albrecht, L. et al. Var gene transcription and PfEMP1 expression in the rosetting and cytoadhesive Plasmodium falciparum clone FCR3S1. 2. Malar. J. 10, 1\u20139 (2011).","journal-title":"Malar. J."},{"key":"2246_CR253","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-9-100","volume":"9","author":"LM Joergensen","year":"2010","unstructured":"Joergensen, L. M. et al. The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs. Malar. J. 9, 1\u201312 (2010).","journal-title":"Malar. J."},{"key":"2246_CR254","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/28660","volume":"394","author":"Q Chen","year":"1998","unstructured":"Chen, Q. et al. Developmental selection of var gene expression in Plasmodium falciparum. Nature 394, 392\u2013395 (1998).","journal-title":"Nature"},{"key":"2246_CR255","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.biocel.2008.12.012","volume":"41","author":"ND Pasternak","year":"2009","unstructured":"Pasternak, N. D. & Dzikowski, R. PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum. Int. J. Biochem. Cell Biol. 41, 1463\u20131466 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2246_CR256","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.mib.2006.06.006","volume":"9","author":"SM Kraemer","year":"2006","unstructured":"Kraemer, S. M. & Smith, J. D. J. C. o. i. m. A family affair: var genes, PfEMP1 binding, and malaria disease. Curr. Opin. Microbiol. 9, 374\u2013380 (2006).","journal-title":"Curr. Opin. Microbiol."},{"key":"2246_CR257","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-2-27","volume":"2","author":"T Lavstsen","year":"2003","unstructured":"Lavstsen, T., Salanti, A., Jensen, A. T., Arnot, D. E. & Theander, T. Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions. Malar. J. 2, 1\u201314 (2003).","journal-title":"Malar. J."},{"key":"2246_CR258","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1084\/jem.20040274","volume":"199","author":"AT Jensen","year":"2004","unstructured":"Jensen, A. T. et al. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J. Exp. Med. 199, 1179\u20131190 (2004).","journal-title":"J. Exp. Med."},{"key":"2246_CR259","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1128\/IAI.02073-05","volume":"74","author":"M Rottmann","year":"2006","unstructured":"Rottmann, M. et al. Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children. Infect. Immun. 74, 3904\u20133911 (2006).","journal-title":"Infect. Immun."},{"key":"2246_CR260","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0166-6851(98)00145-5","volume":"97","author":"JD Smith","year":"1998","unstructured":"Smith, J. D. et al. Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain. Mol. Biochem. Parasitol. 97, 133\u2013148 (1998).","journal-title":"Mol. Biochem. Parasitol."},{"key":"2246_CR261","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1182\/blood.V90.9.3766","volume":"90","author":"DI Baruch","year":"1997","unstructured":"Baruch, D. I. et al. Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence. Blood 90, 3766\u20133775 (1997).","journal-title":"Blood"},{"key":"2246_CR262","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/infdis\/164.1.163","volume":"164","author":"CF Ockenhouse","year":"1991","unstructured":"Ockenhouse, C. F. et al. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-l. J. Infect. Dis. 164, 163\u2013169 (1991).","journal-title":"J. Infect. Dis."},{"key":"2246_CR263","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1459-3","volume":"15","author":"MDP Quintana","year":"2016","unstructured":"Quintana, M. D. P., Angeletti, D., Moll, K., Chen, Q. & Wahlgren, M. Phagocytosis-inducing antibodies to Plasmodium falciparum upon immunization with a recombinant PfEMP1 NTS-DBL1\u03b1 domain. Malar. J. 15, 416 (2016).","journal-title":"Malar. J."},{"key":"2246_CR264","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2905-9","volume":"18","author":"EM Stucke","year":"2019","unstructured":"Stucke, E. M. et al. Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-\u03b1 tag. Malar. J. 18, 273 (2019).","journal-title":"Malar. J."},{"key":"2246_CR265","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-1-0716-2189-9_32","volume":"2470","author":"L Hviid","year":"2022","unstructured":"Hviid, L. & Lopez-Perez, M. Analysis by flow cytometry of \u03b1(2)-macroglobulin and nonimmune IgM-binding to Plasmodium falciparum-infected erythrocytes. Methods Mol. Biol. 2470, 435\u2013444 (2022).","journal-title":"Methods Mol. Biol."},{"key":"2246_CR266","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03201-z","volume":"19","author":"C Harmsen","year":"2020","unstructured":"Harmsen, C. et al. Immunization with virus-like particles conjugated to CIDR\u03b11 domain of Plasmodium falciparum erythrocyte membrane protein 1 induces inhibitory antibodies. Malar. J. 19, 132 (2020).","journal-title":"Malar. J."},{"key":"2246_CR267","doi-asserted-by":"crossref","unstructured":"Kinyua, A. W. et al. Antibodies to PfEMP1 and variant surface antigens: protection after controlled human malaria infection in semi-immune Kenyan adults. J. Infect. 106252 (2024).","DOI":"10.1016\/j.jinf.2024.106252"},{"key":"2246_CR268","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0952-7915(06)80034-8","volume":"4","author":"D Kwiatkowski","year":"1992","unstructured":"Kwiatkowski, D. Malaria: becoming more specific about non-specific immunity. Curr. Opin. Immunol. 4, 425\u2013431 (1992).","journal-title":"Curr. Opin. Immunol."},{"key":"2246_CR269","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0952-7915(02)00368-0","volume":"14","author":"BC Urban","year":"2002","unstructured":"Urban, B. C. & Roberts, D. J. Malaria, monocytes, macrophages and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells. Curr. Opin. Immunol. 14, 458\u2013465 (2002).","journal-title":"Curr. Opin. Immunol."},{"key":"2246_CR270","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1179\/2047773213Y.0000000084","volume":"107","author":"AR Mawson","year":"2013","unstructured":"Mawson, A. R. The pathogenesis of malaria: a new perspective. Pathog. Glob. Health 107, 122\u2013129 (2013).","journal-title":"Pathog. Glob. Health"},{"key":"2246_CR271","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025577","volume":"7","author":"CA Long","year":"2017","unstructured":"Long, C. A. & Zavala, F. Immune responses in malaria. Cold Spring Harb. Perspect. Med. 7, a025577 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2246_CR272","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1600-065X.2008.00671.x","volume":"225","author":"MG Overstreet","year":"2008","unstructured":"Overstreet, M. G., Cockburn, I. A., Chen, Y. C. & Zavala, F. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an \u2018unnatural\u2019 immune response. Immunol. Rev. 225, 272\u2013283 (2008).","journal-title":"Immunol. Rev."},{"key":"2246_CR273","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imr.13202","volume":"316","author":"M Hassert","year":"2023","unstructured":"Hassert, M., Arumugam, S. & Harty, J. T. Memory CD8+ T cell-mediated protection against liver-stage malaria. Immunol. Rev. 316, 84\u2013103 (2023).","journal-title":"Immunol. Rev."},{"key":"2246_CR274","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1128\/IAI.67.11.5604-5614.1999","volume":"67","author":"Y Charoenvit","year":"1999","unstructured":"Charoenvit, Y. et al. CD4+ T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect. Immun. 67, 5604\u20135614 (1999).","journal-title":"Infect. Immun."},{"key":"2246_CR275","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","volume":"18","author":"MN Wykes","year":"2018","unstructured":"Wykes, M. N. & Lewin, S. R. Immune checkpoint blockade in infectious diseases. Nat. Rev. Immunol. 18, 91\u2013104 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"2246_CR276","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49348-0","volume":"15","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. SOD3 suppresses early cellular immune responses to parasite infection. Nat. Commun. 15, 4913 (2024).","journal-title":"Nat. Commun."},{"key":"2246_CR277","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun, L., Su, Y., Jiao, A., Wang, X. & Zhang, B. T cells in health and disease. Signal Transduct. Target Ther. 8, 235 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2246_CR278","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3389\/fimmu.2020.00610","volume":"11","author":"N Hou","year":"2020","unstructured":"Hou, N. et al. Low-complexity repetitive epitopes of Plasmodium falciparum are decoys for humoural immune responses. Front Immunol. 11, 610 (2020).","journal-title":"Front Immunol."},{"key":"2246_CR279","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43181-7","volume":"14","author":"NL Dooley","year":"2023","unstructured":"Dooley, N. L. et al. Single-cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets. Nat. Commun. 14, 7387 (2023).","journal-title":"Nat. Commun."},{"key":"2246_CR280","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4049\/jimmunol.2200899","volume":"210","author":"LL Drewry","year":"2023","unstructured":"Drewry, L. L., Pewe, L. L., Hancox, L. S., Van de Wall, S. & Harty, J. T. CD4 T cell-dependent and -independent roles for IFN-\u03b3 in blood-stage malaria. J. Immunol. 210, 1305\u20131313 (2023).","journal-title":"J. Immunol."},{"key":"2246_CR281","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/pathogens12020319","volume":"12","author":"S Deng","year":"2023","unstructured":"Deng, S., Graham, M. L. & Chen, X. M. The complexity of interferon signaling in host defense against protozoan parasite infection. Pathogens 12, 319 (2023).","journal-title":"Pathogens"},{"key":"2246_CR282","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1086\/592971","volume":"47","author":"MC D\u2019Ombrain","year":"2008","unstructured":"D\u2019Ombrain, M. C. et al. Association of early interferon-\u03b3 production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin. Infect. Dis. 47, 1380\u20131387 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR283","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1128\/IAI.73.9.5645-5653.2005","volume":"73","author":"AJ Mitchell","year":"2005","unstructured":"Mitchell, A. J. et al. Early cytokine production is associated with protection from murine cerebral malaria. Infect. Immun. 73, 5645\u20135653 (2005).","journal-title":"Infect. Immun."},{"key":"2246_CR284","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-2-37","volume":"2","author":"K Chelimo","year":"2003","unstructured":"Chelimo, K., Sumba, P. O., Kazura, J. W., Ofula, A. V. & John, C. C. Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western Kenya. Malar. J. 2, 37 (2003).","journal-title":"Malar. J."},{"key":"2246_CR285","doi-asserted-by":"publisher","first-page":"102646","DOI":"10.1016\/j.parint.2022.102646","volume":"92","author":"Y Ibraheem","year":"2023","unstructured":"Ibraheem, Y., Bayarsaikhan, G. & Inoue, S.-I. Host immunity to plasmodium infection: contribution of Plasmodium berghei to our understanding of T cell-related immune response to blood-stage malaria. Parasitol. Int 92, 102646 (2023).","journal-title":"Parasitol. Int"},{"key":"2246_CR286","doi-asserted-by":"publisher","first-page":"e52870","DOI":"10.1371\/journal.pone.0052870","volume":"7","author":"FM Ndungu","year":"2012","unstructured":"Ndungu, F. M. et al. A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S\/AS01E. PLoS One 7, e52870 (2012).","journal-title":"PLoS One"},{"key":"2246_CR287","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190849","volume":"217","author":"EN Arroyo","year":"2020","unstructured":"Arroyo, E. N. & Pepper, M. B cells are sufficient to prime the dominant CD4+ Tfh response to Plasmodium infection. J. Exp. Med. 217, e20190849 (2020).","journal-title":"J. Exp. Med."},{"key":"2246_CR288","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nm0202-166","volume":"8","author":"LH Carvalho","year":"2002","unstructured":"Carvalho, L. H. et al. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat. Med. 8, 166\u2013170 (2002).","journal-title":"Nat. Med."},{"key":"2246_CR289","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015948","volume":"6","author":"MG Overstreet","year":"2011","unstructured":"Overstreet, M. G., Chen, Y. C., Cockburn, I. A., Tse, S. W. & Zavala, F. CD4+ T cells modulate expansion and survival but not functional properties of effector and memory CD8+ T cells induced by malaria sporozoites. PLoS One 6, e15948 (2011).","journal-title":"PLoS One"},{"key":"2246_CR290","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1126\/science.1175870","volume":"325","author":"RJ Johnston","year":"2009","unstructured":"Johnston, R. J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006\u20131010 (2009).","journal-title":"Science"},{"key":"2246_CR291","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.immuni.2009.07.002","volume":"31","author":"D Yu","year":"2009","unstructured":"Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457\u2013468 (2009).","journal-title":"Immunity"},{"key":"2246_CR292","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aal2192","volume":"2","author":"T L\u00f6nnberg","year":"2017","unstructured":"L\u00f6nnberg, T. et al. Single-cell RNA-seq and computational analysis using temporal mixture modeling resolves TH1\/TFH fate bifurcation in malaria. Sci. Immunol. 2, eaal2192 (2017).","journal-title":"Sci. Immunol."},{"key":"2246_CR293","doi-asserted-by":"publisher","first-page":"e1004715","DOI":"10.1371\/journal.ppat.1004715","volume":"11","author":"D P\u00e9rez-Mazliah","year":"2015","unstructured":"P\u00e9rez-Mazliah, D. et al. Disruption of IL-21 signaling affects T cell-B cell interactions and abrogates protective humoral immunity to malaria. PLoS Pathog. 11, e1004715 (2015).","journal-title":"PLoS Pathog."},{"key":"2246_CR294","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/eji.200839112","volume":"39","author":"OC Finney","year":"2009","unstructured":"Finney, O. C., Nwakanma, D., Conway, D. J., Walther, M. & Riley, E. M. Homeostatic regulation of T effector to Treg ratios in an area of seasonal malaria transmission. Eur. J. Immunol. 39, 1288\u20131300 (2009).","journal-title":"Eur. J. Immunol."},{"key":"2246_CR295","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1128\/IAI.00578-10","volume":"78","author":"RM Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves, R. M. et al. CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses?. Infect. Immun. 78, 4763\u20134772 (2010).","journal-title":"Infect. Immun."},{"key":"2246_CR296","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04055-3","volume":"21","author":"R Chauhan","year":"2022","unstructured":"Chauhan, R. et al. CD4+ICOS+Foxp3+: a sub-population of regulatory T cells contribute to malaria pathogenesis. Malar. J. 21, 32 (2022).","journal-title":"Malar. J."},{"key":"2246_CR297","doi-asserted-by":"publisher","first-page":"966","DOI":"10.4049\/jimmunol.149.3.966","volume":"149","author":"M Sedegah","year":"1992","unstructured":"Sedegah, M. et al. Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J. Immunol. 149, 966\u2013971 (1992).","journal-title":"J. Immunol."},{"key":"2246_CR298","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1074-7613(00)80513-0","volume":"7","author":"DL Doolan","year":"1997","unstructured":"Doolan, D. L. et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7, 97\u2013112 (1997).","journal-title":"Immunity"},{"key":"2246_CR299","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/341323a0","volume":"341","author":"P Romero","year":"1989","unstructured":"Romero, P. et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341, 323\u2013326 (1989).","journal-title":"Nature"},{"key":"2246_CR300","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.4049\/jimmunol.165.2.1123","volume":"165","author":"DL Doolan","year":"2000","unstructured":"Doolan, D. L. et al. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165, 1123\u20131137 (2000).","journal-title":"J. Immunol."},{"key":"2246_CR301","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.1073\/pnas.1633254100","volume":"100","author":"DL Doolan","year":"2003","unstructured":"Doolan, D. L. et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. USA 100, 9952\u20139957 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR302","doi-asserted-by":"crossref","unstructured":"Digitale, J. C. et al. HLA alleles B(*)53:01 and C(*)06:02 are associated with higher risk of P. falciparum Parasitemia in a cohort in Uganda. Front. Immunol. 12, 650028 (2021).","DOI":"10.3389\/fimmu.2021.650028"},{"key":"2246_CR303","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.4049\/jimmunol.165.3.1453","volume":"165","author":"DL Doolan","year":"2000","unstructured":"Doolan, D. L. & Hoffman, S. L. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165, 1453\u20131462 (2000).","journal-title":"J. Immunol."},{"key":"2246_CR304","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","volume":"334","author":"JE Epstein","year":"2011","unstructured":"Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8\u207a T cell immunity. Science 334, 475\u2013480 (2011).","journal-title":"Science"},{"key":"2246_CR305","doi-asserted-by":"publisher","first-page":"e1003303","DOI":"10.1371\/journal.ppat.1003303","volume":"9","author":"JC Hafalla","year":"2013","unstructured":"Hafalla, J. C. et al. Identification of targets of CD8\u207a T cell responses to malaria liver stages by genome-wide epitope profiling. PLoS Pathog. 9, e1003303 (2013).","journal-title":"PLoS Pathog."},{"key":"2246_CR306","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fmicb.2014.00272","volume":"5","author":"N Van Braeckel-Budimir","year":"2014","unstructured":"Van Braeckel-Budimir, N. & Harty, J. T. CD8 T-cell-mediated protection against liver-stage malaria: lessons from a mouse model. Front. Microbiol 5, 272 (2014).","journal-title":"Front. Microbiol"},{"key":"2246_CR307","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/1573395509666131126232327","volume":"9","author":"N Villarino","year":"2013","unstructured":"Villarino, N. & Schmidt, N. W. CD8+ T cell responses to Plasmodium and Intracellular Parasites. Curr. Immunol. Rev. 9, 169\u2013178 (2013).","journal-title":"Curr. Immunol. Rev."},{"key":"2246_CR308","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.4110","volume":"22","author":"AS Ishizuka","year":"2016","unstructured":"Ishizuka, A. S. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614\u2013623 (2016).","journal-title":"Nat. Med."},{"key":"2246_CR309","doi-asserted-by":"publisher","first-page":"e31247","DOI":"10.1371\/journal.pone.0031247","volume":"7","author":"WR Weiss","year":"2012","unstructured":"Weiss, W. R. & Jiang, C. G. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS One 7, e31247 (2012).","journal-title":"PLoS One"},{"key":"2246_CR310","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1073\/pnas.85.2.573","volume":"85","author":"WR Weiss","year":"1988","unstructured":"Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. & Good, M. F. CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl Acad. Sci. USA 85, 573\u2013576 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2246_CR311","doi-asserted-by":"publisher","first-page":"e1000998","DOI":"10.1371\/journal.ppat.1000998","volume":"6","author":"NW Schmidt","year":"2010","unstructured":"Schmidt, N. W., Butler, N. S., Badovinac, V. P. & Harty, J. T. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog. 6, e1000998 (2010).","journal-title":"PLoS Pathog."},{"key":"2246_CR312","doi-asserted-by":"crossref","unstructured":"Mouwenda, Y. D. et al. Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans. JCI insight 9 (2024).","DOI":"10.1172\/jci.insight.170210"},{"key":"2246_CR313","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","volume":"35","author":"N Zhang","year":"2011","unstructured":"Zhang, N. & Bevan, M. J. CD8+ T cells: foot soldiers of the immune system. Immunity 35, 161\u2013168 (2011).","journal-title":"Immunity"},{"key":"2246_CR314","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nm1628","volume":"13","author":"S Chakravarty","year":"2007","unstructured":"Chakravarty, S. et al. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13, 1035\u20131041 (2007).","journal-title":"Nat. Med."},{"key":"2246_CR315","doi-asserted-by":"publisher","first-page":"e1004637","DOI":"10.1371\/journal.ppat.1004637","volume":"11","author":"AJ Radtke","year":"2015","unstructured":"Radtke, A. J. et al. Lymph-node resident CD8\u03b1+ dendritic cells capture antigens from migratory malaria sporozoites and induce CD8+ T cell responses. PLoS Pathog. 11, e1004637 (2015).","journal-title":"PLoS Pathog."},{"key":"2246_CR316","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.chom.2011.05.008","volume":"9","author":"NS Butler","year":"2011","unstructured":"Butler, N. S. et al. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9, 451\u2013462 (2011).","journal-title":"Cell Host Microbe"},{"key":"2246_CR317","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.ijpara.2007.05.005","volume":"37","author":"B Douradinha","year":"2007","unstructured":"Douradinha, B. et al. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int. J. Parasitol. 37, 1511\u20131519 (2007).","journal-title":"Int. J. Parasitol."},{"key":"2246_CR318","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1038\/cti.2016.60","volume":"5","author":"LE Holz","year":"2016","unstructured":"Holz, L. E., Fernandez-Ruiz, D. & Heath, W. R. Protective immunity to liver-stage malaria. Clin. Transl. Immunol. 5, e105 (2016).","journal-title":"Clin. Transl. Immunol."},{"key":"2246_CR319","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.imbio.2012.05.018","volume":"218","author":"V Ryg-Cornejo","year":"2013","unstructured":"Ryg-Cornejo, V. et al. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection. Immunobiology 218, 263\u2013271 (2013).","journal-title":"Immunobiology"},{"key":"2246_CR320","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1084\/jem.20042463","volume":"202","author":"A Morrot","year":"2005","unstructured":"Morrot, A., Hafalla, J. C., Cockburn, I. A., Carvalho, L. H. & Zavala, F. IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. J. Exp. Med. 202, 551\u2013560 (2005).","journal-title":"J. Exp. Med."},{"key":"2246_CR321","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2012.06.003","volume":"277","author":"HB da Silva","year":"2012","unstructured":"da Silva, H. B. et al. Early skin immunological disturbance after Plasmodium-infected mosquito bites. Cell Immunol. 277, 22\u201332 (2012).","journal-title":"Cell Immunol."},{"key":"2246_CR322","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.molbiopara.2006.08.005","volume":"150","author":"HM Kyriacou","year":"2006","unstructured":"Kyriacou, H. M. et al. Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol. Biochem. Parasitol. 150, 211\u2013218 (2006).","journal-title":"Mol. Biochem. Parasitol."},{"key":"2246_CR323","doi-asserted-by":"publisher","DOI":"10.1038\/srep26773","volume":"6","author":"GI Bertin","year":"2016","unstructured":"Bertin, G. I. et al. Proteomic analysis of Plasmodium falciparum parasites from patients with cerebral and uncomplicated malaria. Sci. Rep. 6, 26773 (2016).","journal-title":"Sci. Rep."},{"key":"2246_CR324","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-3024.2000.00342.x","volume":"22","author":"D Mazier","year":"2000","unstructured":"Mazier, D., Nitcheu, J. & Idrissa-Boubou, M. Cerebral malaria and immunogenetics. Parasite Immunol. 22, 613\u2013623 (2000).","journal-title":"Parasite Immunol."},{"key":"2246_CR325","first-page":"412","volume":"42","author":"LJ Mackey","year":"1980","unstructured":"Mackey, L. J., Hochmann, A., June, C. H., Contreras, C. E. & Lambert, P. H. Immunopathological aspects of Plasmodium berghei infection in five strains of mice. II. Immunopathology of cerebral and other tissue lesions during the infection. Clin. Exp. Immunol. 42, 412\u2013420 (1980).","journal-title":"Clin. Exp. Immunol."},{"key":"2246_CR326","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/brain\/awad319","volume":"147","author":"CE Fain","year":"2023","unstructured":"Fain, C. E. et al. Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria. Brain 147, 566\u2013589 (2023).","journal-title":"Brain"},{"key":"2246_CR327","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14431","volume":"30","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. CD8+ T cell infiltration and proliferation in the brainstem during experimental cerebral malaria. CNS Neurosci. Ther. 30, e14431 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"2246_CR328","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.4049\/jimmunol.0903529","volume":"184","author":"NS Butler","year":"2010","unstructured":"Butler, N. S., Schmidt, N. W. & Harty, J. T. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J. Immunol. 184, 2528\u20132538 (2010).","journal-title":"J. Immunol."},{"key":"2246_CR329","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.4049\/jimmunol.139.12.4192","volume":"139","author":"S Mellouk","year":"1987","unstructured":"Mellouk, S. et al. Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J. Immunol. 139, 4192\u20134195 (1987).","journal-title":"J. Immunol."},{"key":"2246_CR330","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109956","volume":"37","author":"MN Lefebvre","year":"2021","unstructured":"Lefebvre, M. N. et al. Expeditious recruitment of circulating memory CD8 T+ cells to the liver facilitates control of malaria. Cell Rep. 37, 109956 (2021).","journal-title":"Cell Rep."},{"key":"2246_CR331","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/eji.202149424","volume":"52","author":"J Brandi","year":"2022","unstructured":"Brandi, J. et al. T cells expressing multiple co-inhibitory molecules in acute malaria are not exhausted but exert a suppressive function in mice. Eur. J. Immunol. 52, 312\u2013327 (2022).","journal-title":"Eur. J. Immunol."},{"key":"2246_CR332","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","volume":"32","author":"YH Chien","year":"2014","unstructured":"Chien, Y. H., Meyer, C. & Bonneville, M. \u03b3\u03b4 T cells: first line of defense and beyond. Annu. Rev. Immunol. 32, 121\u2013155 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"2246_CR333","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000086659","volume":"86","author":"W Holtmeier","year":"2005","unstructured":"Holtmeier, W. & Kabelitz, D. gammadelta T cells link innate and adaptive immune responses. Chem. Immunol. Allergy 86, 151\u2013183 (2005).","journal-title":"Chem. Immunol. Allergy"},{"key":"2246_CR334","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1146\/annurev.immunol.18.1.975","volume":"18","author":"AC Hayday","year":"2000","unstructured":"Hayday, A. C. \u03b3\u03b4 cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18, 975\u20131026 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"2246_CR335","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nri797","volume":"2","author":"SR Carding","year":"2002","unstructured":"Carding, S. R. & Egan, P. J. \u03b3\u03b4T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2, 336\u2013345 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"2246_CR336","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1128\/IAI.69.5.3190-3196.2001","volume":"69","author":"L Hviid","year":"2001","unstructured":"Hviid, L. et al. Perturbation and proinflammatory type activation of V delta 1+ \u03b3\u03b4 T cells in African children with Plasmodium falciparum malaria. Infect. Immun. 69, 3190\u20133196 (2001).","journal-title":"Infect. Immun."},{"key":"2246_CR337","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/infdis\/162.1.283-a","volume":"162","author":"C Roussilhon","year":"1990","unstructured":"Roussilhon, C., Agrapart, M., Ballet, J. J. & Bensussan, A. T lymphocytes bearing the \u03b3\u03b4 T cell receptor in patients with acute Plasmodium falciparum malaria. J. Infect. Dis. 162, 283\u2013285 (1990).","journal-title":"J. Infect. Dis."},{"key":"2246_CR338","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/0035-9203(93)90299-6","volume":"87","author":"M Goodier","year":"1993","unstructured":"Goodier, M. et al. \u0393\u03b4 T cells in the peripheral blood of individuals from an area of holoendemic Plasmodium falciparum transmission. Trans. R. Soc. Trop. Med. Hyg. 87, 692\u2013696 (1993).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"2246_CR339","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1086\/322522","volume":"33","author":"E Schwartz","year":"2001","unstructured":"Schwartz, E., Sadetzki, S., Murad, H. & Raveh, D. Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients. Clin. Infect. Dis. 33, 1774\u20131777 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR340","doi-asserted-by":"publisher","first-page":"e1002389","DOI":"10.1371\/journal.ppat.1002389","volume":"7","author":"AC Teirlinck","year":"2011","unstructured":"Teirlinck, A. C. et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 7, e1002389 (2011).","journal-title":"PLoS Pathog."},{"key":"2246_CR341","doi-asserted-by":"crossref","unstructured":"Nana, C. M. M. et al. Phenotypic changes of \u03b3\u03b4 T cells in Plasmodium falciparum placental malaria and pregnancy outcomes in women at delivery in Cameroon. Front. Immunol. 15 (2024).","DOI":"10.3389\/fimmu.2024.1385380"},{"key":"2246_CR342","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/imm.12997","volume":"155","author":"SI Inoue","year":"2018","unstructured":"Inoue, S. I., Niikura, M., Asahi, H., Kawakami, Y. & Kobayashi, F. \u03b3\u03b4 T cells modulate humoral immunity against Plasmodium berghei infection. Immunology 155, 519\u2013532 (2018).","journal-title":"Immunology"},{"key":"2246_CR343","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.immuni.2018.01.009","volume":"48","author":"MR Mamedov","year":"2018","unstructured":"Mamedov, M. R. et al. A macrophage colony-stimulating-factor-producing \u03b3\u03b4 T cell subset prevents malarial parasitemic recurrence. Immunity 48, 350\u2013363 (2018).","journal-title":"Immunity"},{"key":"2246_CR344","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.4049\/jimmunol.1700314","volume":"199","author":"I Zaidi","year":"2017","unstructured":"Zaidi, I. et al. \u03b3\u03b4 T cells are required for the induction of sterile immunity during irradiated sporozoite vaccinations. J. Immunol. 199, 3781\u20133788 (2017).","journal-title":"J. Immunol."},{"key":"2246_CR345","doi-asserted-by":"publisher","first-page":"e12628","DOI":"10.1111\/pim.12628","volume":"41","author":"AM Moormann","year":"2019","unstructured":"Moormann, A. M., Nixon, C. E. & Forconi, C. S. Immune effector mechanisms in malaria: an update focusing on human immunity. Parasite Immunol. 41, e12628 (2019).","journal-title":"Parasite Immunol."},{"key":"2246_CR346","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1586\/erv.12.144","volume":"12","author":"JG Beeson","year":"2013","unstructured":"Beeson, J. G., Chan, J.-A. & Fowkes, F. PfEMP1 as a target of human immunity and a vaccine candidate against malaria. Expert Rev. Vaccines 12, 105\u2013108 (2013).","journal-title":"Expert Rev. Vaccines"},{"key":"2246_CR347","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1017\/S0031182009990515","volume":"136","author":"AJP Holder","year":"2009","unstructured":"Holder, A. J. P. The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria. Parasitology 136, 1445\u20131456 (2009).","journal-title":"Parasitology"},{"key":"2246_CR348","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-77","volume":"9","author":"U Woehlbier","year":"2010","unstructured":"Woehlbier, U., Epp, C., Hackett, F., Blackman, M. J. & Bujard, H. J. M. j. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion. Malar. J. 9, 77 (2010).","journal-title":"Malar. J."},{"key":"2246_CR349","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41590-024-01938-2","volume":"25","author":"LT Wang","year":"2024","unstructured":"Wang, L. T., Idris, A. H., Kisalu, N. K., Crompton, P. D. & Seder, R. Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention. Nat. Immunol. 25, 1\u201316 (2024).","journal-title":"Nat. Immunol."},{"key":"2246_CR350","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.immuni.2020.08.014","volume":"53","author":"LT Wang","year":"2020","unstructured":"Wang, L. T. et al. A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver. Immunity 53, 733\u2013744. e738 (2020).","journal-title":"Immunity"},{"key":"2246_CR351","first-page":"113","volume":"20","author":"D Chatterjee","year":"2021","unstructured":"Chatterjee, D. & Cockburn, I. The challenges of a circumsporozoite protein-based malaria vaccine. Vaccines 20, 113\u2013125 (2021).","journal-title":"Vaccines"},{"key":"2246_CR352","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1348-9","volume":"15","author":"S Chaudhury","year":"2016","unstructured":"Chaudhury, S. et al. The biological function of antibodies induced by the RTS, S\/AS01 malaria vaccine candidate is determined by their fine specificity. Malar. J. 15, 1\u201312 (2016).","journal-title":"Malar. J."},{"key":"2246_CR353","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1615","volume":"2","author":"AD Douglas","year":"2011","unstructured":"Douglas, A. D. et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2, 601 (2011).","journal-title":"Nat. Commun."},{"key":"2246_CR354","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/imr.12802","volume":"293","author":"L Kurtovic","year":"2020","unstructured":"Kurtovic, L. et al. Complement in malaria immunity and vaccines. Immunol. Rev. 293, 38\u201356 (2020).","journal-title":"Immunol. Rev."},{"key":"2246_CR355","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ijpara.2017.05.004","volume":"47","author":"DL Hill","year":"2017","unstructured":"Hill, D. L., Schofield, L. & Wilson, D. W. IgG opsonization of merozoites: multiple immune mechanisms for malaria vaccine development. Int. J. Parasitol. 47, 585\u2013595 (2017).","journal-title":"Int. J. Parasitol."},{"key":"2246_CR356","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/CMR.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan, D. L., Doba\u00f1o, C. & Baird, J. K. Acquired immunity to malaria. Clin. Microbiol. Rev. 22, 13\u201336 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"2246_CR357","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40878-7","volume":"14","author":"PN Patel","year":"2023","unstructured":"Patel, P. N. et al. Structure-based design of a strain-transcending AMA1-RON2L malaria vaccine. Nat. Commun. 14, 5345 (2023).","journal-title":"Nat. Commun."},{"key":"2246_CR358","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4049\/jimmunol.171.1.317","volume":"171","author":"AH Achtman","year":"2003","unstructured":"Achtman, A. H., Khan, M., MacLennan, I. & Langhorne, J. Plasmodium chabaudi chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J. Immunol. 171, 317\u2013324 (2003).","journal-title":"J. Immunol."},{"key":"2246_CR359","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1128\/IAI.72.9.5412-5418.2004","volume":"72","author":"D Donati","year":"2004","unstructured":"Donati, D. et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect. Immun. 72, 5412\u20135418 (2004).","journal-title":"Infect. Immun."},{"key":"2246_CR360","doi-asserted-by":"crossref","unstructured":"Pack, A. D. et al. Hemozoin-mediated inflammasome activation limits long-lived anti-malarial immunity. Cell Rep. 36 (2021).","DOI":"10.1016\/j.celrep.2021.109586"},{"key":"2246_CR361","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41590-020-0678-5","volume":"21","author":"R Vijay","year":"2020","unstructured":"Vijay, R. et al. Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria. Nat. Immunol. 21, 790\u2013801 (2020).","journal-title":"Nat. Immunol."},{"key":"2246_CR362","doi-asserted-by":"crossref","unstructured":"Chin, S. S., Chorro, L., Chan, J. & Lauvau, G. Splenic innate B1 B cell plasmablasts produce sustained granulocyte-macrophage colony-stimulating factor and interleukin-3 cytokines during murine malaria infections. Infect. Immun. 87 (2019).","DOI":"10.1128\/IAI.00482-19"},{"key":"2246_CR363","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41590-018-0228-6","volume":"19","author":"IA Cockburn","year":"2018","unstructured":"Cockburn, I. A. & Seder, R. A. Malaria prevention: from immunological concepts to effective vaccines and protective antibodies. Nat. Immunol. 19, 1199\u20131211 (2018).","journal-title":"Nat. Immunol."},{"key":"2246_CR364","doi-asserted-by":"crossref","unstructured":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31\u201345 (2015).","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"2246_CR365","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/infdis\/jiaa144","volume":"224","author":"L Kurtovic","year":"2021","unstructured":"Kurtovic, L. et al. Multifunctional antibodies are Iinduced by the RTS,S malaria vaccine and associated with protection in a phase 1\/2a trial. J. Infect. Dis. 224, 1128\u20131138 (2021).","journal-title":"J. Infect. Dis."},{"key":"2246_CR366","first-page":"1269","volume":"2","author":"J Das","year":"2021","unstructured":"Das, J. et al. Delayed fractional dosing with RTS,S\/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies. Medicines 2, 1269\u20131286.e1269 (2021).","journal-title":"Medicines"},{"key":"2246_CR367","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08699-7","volume":"23","author":"GJ Bell","year":"2023","unstructured":"Bell, G. J. et al. Background malaria incidence and parasitemia during the three-dose RTS,S\/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria. BMC Infect. Dis. 23, 716 (2023).","journal-title":"BMC Infect. Dis."},{"key":"2246_CR368","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0160-2","volume":"5","author":"A Blank","year":"2020","unstructured":"Blank, A. et al. Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial. npj Vaccines 5, 10 (2020).","journal-title":"npj Vaccines"},{"key":"2246_CR369","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03548-3","volume":"20","author":"M Seidel-Greven","year":"2021","unstructured":"Seidel-Greven, M. et al. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity. Malar. J. 20, 37 (2021).","journal-title":"Malar. J."},{"key":"2246_CR370","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12033-020-00271-x","volume":"62","author":"EM Mil\u00e1n-Noris","year":"2020","unstructured":"Mil\u00e1n-Noris, E. M. et al. An AMA1\/MSP1(19) adjuvanted malaria transplastomic plant-based vaccine induces immune responses in test animals. Mol. Biotechnol. 62, 534\u2013545 (2020).","journal-title":"Mol. Biotechnol."},{"key":"2246_CR371","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00716-18","volume":"87","author":"ND Salinas","year":"2019","unstructured":"Salinas, N. D., Paing, M. M., Adhikari, J., Gross, M. L. & Tolia, N. Moderately neutralizing epitopes in nonfunctional regions dominate the antibody response to Plasmodium falciparum EBA-140. Infect. Immun. 87, e00716 (2019).","journal-title":"Infect. Immun."},{"key":"2246_CR372","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S1473-3099(24)00312-8","volume":"24","author":"SE Silk","year":"2024","unstructured":"Silk, S. E. et al. Blood-stage malaria vaccine candidate RH5.1\/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial. Lancet Infect. Dis. 24, 1105\u20131117 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR373","unstructured":"Natama, H. M. et al. Safety and efficacy of the blood-stage malaria vaccine RH5.1\/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children. Lancet Infect. Dis.S1473-3099(24)00752-7."},{"key":"2246_CR374","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48721-3","volume":"15","author":"BG Williams","year":"2024","unstructured":"Williams, B. G. et al. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex. Nat. Commun. 15, 4857 (2024).","journal-title":"Nat. Commun."},{"key":"2246_CR375","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00309-4","volume":"6","author":"NG Bender","year":"2021","unstructured":"Bender, N. G. et al. Immunofocusing humoral immunity potentiates the functional efficacy of the AnAPN1 malaria transmission-blocking vaccine antigen. NPJ Vaccines 6, 49 (2021).","journal-title":"NPJ Vaccines"},{"key":"2246_CR376","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67222-z","volume":"10","author":"N Kuamsab","year":"2020","unstructured":"Kuamsab, N., Putaporntip, C., Pattanawong, U. & Jongwutiwes, S. Insights into the molecular diversity of Plasmodium vivax merozoite surface protein-3\u03b3 (pvmsp3\u03b3), a polymorphic member in the msp3 multi-gene family. Sci. Rep. 10, 10977 (2020).","journal-title":"Sci. Rep."},{"key":"2246_CR377","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59153-w","volume":"14","author":"N Kuamsab","year":"2024","unstructured":"Kuamsab, N. et al. Anti-Plasmodium vivax merozoite surface protein 3\u03b3 (PvMSP3 \u03b3) antibodies upon natural infection. Sci. Rep. 14, 9595 (2024).","journal-title":"Sci. Rep."},{"key":"2246_CR378","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03207-7","volume":"19","author":"J Uwase","year":"2020","unstructured":"Uwase, J. et al. Immunogenicity analysis of conserved fragments in Plasmodium ovale species merozoite surface protein 4. Malar. J. 19, 126 (2020).","journal-title":"Malar. J."},{"key":"2246_CR379","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fimmu.2020.00893","volume":"11","author":"BN Kanoi","year":"2020","unstructured":"Kanoi, B. N. et al. Global repertoire of human antibodies against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a malaria-exposed population. Front. Immunol. 11, 893 (2020).","journal-title":"Front. Immunol."},{"key":"2246_CR380","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ni.f.205","volume":"9","author":"J Langhorne","year":"2008","unstructured":"Langhorne, J., Ndungu, F. M., Sponaas, A.-M. & Marsh, K. Immunity to malaria: more questions than answers. Nat. Immunol. 9, 725\u2013732 (2008).","journal-title":"Nat. Immunol."},{"key":"2246_CR381","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/cid\/ciab1017","volume":"75","author":"I Sagara","year":"2022","unstructured":"Sagara, I. et al. The anti-circumsporozoite antibody response of children to seasonal vaccination with the RTS,S\/AS01E malaria vaccine. Clin. Infect. Dis. 75, 613\u2013622 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR382","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","volume":"12","author":"TUJ Bruun","year":"2018","unstructured":"Bruun, T. U. J., Andersson, A. C., Draper, S. J. & Howarth, M. Engineering a rugged nanoscaffold to enhance plug-and-display vaccination. ACS Nano 12, 8855\u20138866 (2018).","journal-title":"ACS Nano"},{"key":"2246_CR383","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.it.2022.03.005","volume":"43","author":"JJC McGrath","year":"2022","unstructured":"McGrath, J. J. C., Li, L. & Wilson, P. C. Memory B cell diversity: insights for optimized vaccine design. Trends Immunol. 43, 343\u2013354 (2022).","journal-title":"Trends Immunol."},{"key":"2246_CR384","doi-asserted-by":"publisher","first-page":"102234","DOI":"10.1016\/j.coi.2022.102234","volume":"78","author":"C Britto","year":"2022","unstructured":"Britto, C. & Alter, G. The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design. Curr. Opin. Immunol. 78, 102234 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"2246_CR385","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3201\/eid1705.101527","volume":"17","author":"E Seringe","year":"2011","unstructured":"Seringe, E. et al. Severe imported Plasmodium falciparum malaria, France, 1996-2003. Emerg. Infect. Dis. 17, 807\u2013813 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"2246_CR386","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","volume":"16","author":"K Haldar","year":"2018","unstructured":"Haldar, K., Bhattacharjee, S. & Safeukui, I. Drug resistance in Plasmodium. Nat. Rev. Microbiol. 16, 156\u2013170 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"2246_CR387","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S2352-4642(20)30127-9","volume":"4","author":"EA Ashley","year":"2020","unstructured":"Ashley, E. A. & Poespoprodjo, J. A. Treatment and prevention of malaria in children. Lancet Child Adolesc. Health 4, 775\u2013789 (2020).","journal-title":"Lancet Child Adolesc. Health"},{"key":"2246_CR388","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40264-014-0261-9","volume":"38","author":"SD Kovacs","year":"2015","unstructured":"Kovacs, S. D., Rijken, M. J. & Stergachis, A. Treating severe malaria in pregnancy: a review of the evidence. Drug Saf. 38, 165\u2013181 (2015).","journal-title":"Drug Saf."},{"key":"2246_CR389","doi-asserted-by":"publisher","first-page":"e0011449","DOI":"10.1371\/journal.pntd.0011449","volume":"17","author":"FW Ojara","year":"2023","unstructured":"Ojara, F. W., Kawuma, A. N. & Waitt, C. Systematic review on maternal-to-infant transfer of drugs through breast milk during the treatment of malaria, tuberculosis, and neglected tropical diseases. PLoS Negl. Trop. Dis. 17, e0011449 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2246_CR390","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7371681","volume":"2020","author":"A Derbie","year":"2020","unstructured":"Derbie, A. et al. Therapeutic Efficacy of Artemether-Lumefantrine (Coartem\u00ae) for the treatment of uncomplicated falciparum malaria in Africa: a systematic review. J. Parasitol. Res 2020, 7371681 (2020).","journal-title":"J. Parasitol. Res"},{"key":"2246_CR391","first-page":"CD004529","volume":"1","author":"A Blanshard","year":"2021","unstructured":"Blanshard, A. & Hine, P. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst. Rev. 1, CD004529 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2246_CR392","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1473-3099(23)00430-9","volume":"24","author":"RJ Commons","year":"2024","unstructured":"Commons, R. J. et al. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. Lancet Infect. Dis. 24, 172\u2013183 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR393","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/cid\/ciad638","volume":"78","author":"L Castro","year":"2023","unstructured":"Castro, L., Ridpath, A., Mace, K. & Gutman, J. R. Have you heard the news? Artemether-lumefantrine is now recommended for ALL uncomplicated malaria in the United States, including in pregnancy. Clin. Infect. Dis. 78, 245\u2013247 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR394","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1371\/journal.pmed.0050253","volume":"5","author":"R McGready","year":"2008","unstructured":"McGready, R. et al. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. PLoS Med. 5, e253 (2008).","journal-title":"PLoS Med."},{"key":"2246_CR395","first-page":"434","volume":"15","author":"S Borrmann","year":"2010","unstructured":"Borrmann, S. et al. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. Trop. Med. Int. Health 15, 434\u2013441 (2010).","journal-title":"Trop. Med. Int. Health"},{"key":"2246_CR396","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-3156.2006.01784.x","volume":"12","author":"EA Ashley","year":"2007","unstructured":"Ashley, E. A. et al. How much fat is necessary to optimize lumefantrine oral bioavailability?. Trop. Med. Int. Health 12, 195\u2013200 (2007).","journal-title":"Trop. Med. Int. Health"},{"key":"2246_CR397","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/jtm.12088","volume":"21","author":"E Leshem","year":"2014","unstructured":"Leshem, E., Meltzer, E., Stienlauf, S., Kopel, E. & Schwartz, E. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-Saharan Africa. J. Travel. Med. 21, 82\u201385 (2014).","journal-title":"J. Travel. Med."},{"key":"2246_CR398","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2165\/00003495-200363060-00006","volume":"63","author":"K McKeage","year":"2003","unstructured":"McKeage, K. & Scott, L. Atovaquone\/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. Drugs 63, 597\u2013623 (2003).","journal-title":"Drugs"},{"key":"2246_CR399","doi-asserted-by":"publisher","first-page":"tay138","DOI":"10.1093\/jtm\/tay138","volume":"26","author":"RC Mayer","year":"2019","unstructured":"Mayer, R. C., Tan, K. R. & Gutman, J. R. Safety of atovaquone-proguanil during pregnancy. J. Travel. Med. 26, tay138 (2019).","journal-title":"J. Travel. Med."},{"key":"2246_CR400","doi-asserted-by":"publisher","first-page":"taaa074","DOI":"10.1093\/jtm\/taaa074","volume":"27","author":"KL McKinney","year":"2020","unstructured":"McKinney, K. L., Wu, H. M., Tan, K. R. & Gutman, J. R. Malaria in the pregnant traveler. J. Travel. Med. 27, taaa074 (2020).","journal-title":"J. Travel. Med."},{"key":"2246_CR401","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1708-8305.2009.00362.x","volume":"17","author":"LH Chen","year":"2009","unstructured":"Chen, L. H. et al. Breastfeeding travelers: precautions and recommendations. J. Travel. Med. 17, 32\u201347 (2009).","journal-title":"J. Travel. Med."},{"key":"2246_CR402","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley, E. A., Recht, J. & White, N. J. Primaquine: the risks and the benefits. Malar. J. 13, 418 (2014).","journal-title":"Malar. J."},{"key":"2246_CR403","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/cid\/ciy235","volume":"67","author":"ME Gilder","year":"2018","unstructured":"Gilder, M. E. et al. Primaquine pharmacokinetics in lactating women and breastfed infant exposures. Clin. Infect. Dis. 67, 1000\u20131007 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR404","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-84","volume":"7","author":"S Yeung","year":"2008","unstructured":"Yeung, S., Van Damme, W., Socheat, D., White, N. J. & Mills, A. Cost of increasing access to artemisinin combination therapy: the Cambodian experience. Malar. J. 7, 84 (2008).","journal-title":"Malar. J."},{"key":"2246_CR405","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2844-5","volume":"18","author":"TO Apinjoh","year":"2019","unstructured":"Apinjoh, T. O., Ouattara, A., Titanji, V. P. K., Djimde, A. & Amambua-Ngwa, A. Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: is there an ideal tool for resource-limited sub-Saharan Africa?. Malar. J. 18, 217 (2019).","journal-title":"Malar. J."},{"key":"2246_CR406","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","volume":"37","author":"M Duffey","year":"2021","unstructured":"Duffey, M. et al. Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. Trends Parasitol. 37, 709\u2013721 (2021).","journal-title":"Trends Parasitol."},{"key":"2246_CR407","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpddr.2021.04.002","volume":"16","author":"LE Buyon","year":"2021","unstructured":"Buyon, L. E., Elsworth, B. & Duraisingh, M. T. The molecular basis of antimalarial drug resistance in Plasmodium vivax. Int. J. Parasitol. Drugs Drug Resist. 16, 23\u201337 (2021).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"2246_CR408","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1168243","volume":"325","author":"JW Li","year":"2009","unstructured":"Li, J. W. & Vederas, J. C. Drug discovery and natural products: end of an era or an endless frontier?. Science 325, 161\u2013165 (2009).","journal-title":"Science"},{"key":"2246_CR409","doi-asserted-by":"publisher","first-page":"e1003203","DOI":"10.1371\/journal.pmed.1003203","volume":"17","author":"RE Watts","year":"2020","unstructured":"Watts, R. E. et al. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: a pilot and a randomised volunteer infection study in Australia. PLoS Med. 17, e1003203 (2020).","journal-title":"PLoS Med."},{"key":"2246_CR410","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","volume":"22","author":"JL Siqueira-Neto","year":"2023","unstructured":"Siqueira-Neto, J. L. et al. Antimalarial drug discovery: progress and approaches. Nat. Rev. Drug Discov. 22, 807\u2013826 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2246_CR411","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","volume":"29","author":"T Yang","year":"2019","unstructured":"Yang, T. et al. Decreased K13 abundance reduces hemoglobin catabolism and proteotoxic stress, underpinning artemisinin resistance. Cell Rep. 29, 2917\u20132928 (2019).","journal-title":"Cell Rep."},{"key":"2246_CR412","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50\u201355 (2014).","journal-title":"Nature"},{"key":"2246_CR413","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nbt.2925","volume":"32","author":"M Ghorbal","year":"2014","unstructured":"Ghorbal, M. et al. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat. Biotechnol. 32, 819\u2013821 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2246_CR414","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer, J. et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347, 428\u2013431 (2015).","journal-title":"Science"},{"key":"2246_CR415","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","volume":"20","author":"M Imwong","year":"2020","unstructured":"Imwong, M. et al. Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study. Lancet Infect. Dis. 20, 1470\u20131480 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR416","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJMc2117480","volume":"386","author":"BH Stokes","year":"2022","unstructured":"Stokes, B. H., Ward, K. E. & Fidock, D. A. Evidence of artemisinin-resistant malaria in Africa. N. Engl. J. Med. 386, 1385\u20131386 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2246_CR417","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66277","volume":"10","author":"BH Stokes","year":"2021","unstructured":"Stokes, B. H. et al. Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness. ELife 10, e66277 (2021).","journal-title":"ELife"},{"key":"2246_CR418","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1260403","volume":"347","author":"S Mok","year":"2015","unstructured":"Mok, S. et al. Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science 347, 431\u2013435 (2015).","journal-title":"Science"},{"key":"2246_CR419","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/jac\/dkaa250","volume":"75","author":"T Reyser","year":"2020","unstructured":"Reyser, T. et al. Identification of compounds active against quiescent artemisinin-resistant Plasmodium falciparum parasites via the quiescent-stage survival assay (QSA). J. Antimicrob. Chemother. 75, 2826\u20132834 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"2246_CR420","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.pt.2020.03.006","volume":"36","author":"SC Xie","year":"2020","unstructured":"Xie, S. C., Ralph, S. A. & Tilley, L. K13, the cytostome, and artemisinin resistance. Trends Parasitol. 36, 533\u2013544 (2020).","journal-title":"Trends Parasitol."},{"key":"2246_CR421","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1128\/AAC.00197-15","volume":"59","author":"A Hott","year":"2015","unstructured":"Hott, A. et al. Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes. Antimicrob. Agents Chemother. 59, 3156\u20133167 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2246_CR422","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00753-21","volume":"12","author":"Connelly","year":"2021","unstructured":"Connelly et al. Restructured mitochondrial-nuclear interaction in Plasmodium falciparum dormancy and persister survival after artemisinin exposure. mBio 12, e0075321 (2021).","journal-title":"mBio"},{"key":"2246_CR423","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20805-w","volume":"12","author":"S Mok","year":"2021","unstructured":"Mok, S. et al. Artemisinin-resistant K13 mutations rewire Plasmodium falciparum\u2019s intra-erythrocytic metabolic program to enhance survival. Nat. Commun. 12, 530 (2021).","journal-title":"Nat. Commun."},{"key":"2246_CR424","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1021\/jm00035a003","volume":"37","author":"GH Posner","year":"1994","unstructured":"Posner, G. H. et al. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity. J. Med. Chem. 37, 1256\u20131258 (1994).","journal-title":"J. Med. Chem."},{"key":"2246_CR425","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105725","volume":"26","author":"X Yu","year":"2023","unstructured":"Yu, X. et al. Ring-stage growth arrest: metabolic basis of artemisinin tolerance in Plasmodium falciparum. iScience 26, 105725 (2023).","journal-title":"iScience"},{"key":"2246_CR426","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41564-024-01664-3","volume":"9","author":"JL Small-Saunders","year":"2024","unstructured":"Small-Saunders, J. L. et al. tRNA modification reprogramming contributes to artemisinin resistance in Plasmodium falciparum. Nat. Microbiol. 9, 1483\u20131498 (2024).","journal-title":"Nat. Microbiol."},{"key":"2246_CR427","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05652-0","volume":"9","author":"LS Ross","year":"2018","unstructured":"Ross, L. S. et al. Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat. Commun. 9, 3314 (2018).","journal-title":"Nat. Commun."},{"key":"2246_CR428","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/infdis\/jiab055","volume":"224","author":"B Shrestha","year":"2021","unstructured":"Shrestha, B. et al. Distribution and temporal dynamics of Plasmodium falciparum chloroquine resistance transporter mutations associated with piperaquine resistance in Northern Cambodia. J. Infect. Dis. 224, 1077\u20131085 (2021).","journal-title":"J. Infect. Dis."},{"key":"2246_CR429","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103680","volume":"73","author":"WC Lee","year":"2021","unstructured":"Lee, W. C. et al. Plasmodium falciparum rosetting protects schizonts against artemisinin. EBioMedicine 73, 103680 (2021).","journal-title":"EBioMedicine"},{"key":"2246_CR430","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","volume":"28","author":"A Ecker","year":"2012","unstructured":"Ecker, A., Lehane, A. M., Clain, J. & Fidock, D. A. PfCRT and its role in antimalarial drug resistance. Trends Parasitol. 28, 504\u2013514 (2012).","journal-title":"Trends Parasitol."},{"key":"2246_CR431","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock, D. A. et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6, 861\u2013871 (2000).","journal-title":"Mol. Cell"},{"key":"2246_CR432","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-42","volume":"10","author":"W Chaijaroenkul","year":"2011","unstructured":"Chaijaroenkul, W. et al. Sequence and gene expression of chloroquine resistance transporter (pfcrt) in the association of in vitro drugs resistance of Plasmodium falciparum. Malar. J. 10, 42 (2011).","journal-title":"Malar. J."},{"key":"2246_CR433","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1126\/science.1074045","volume":"298","author":"AB Sidhu","year":"2002","unstructured":"Sidhu, A. B., Verdier-Pinard, D. & Fidock, D. A. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298, 210\u2013213 (2002).","journal-title":"Science"},{"key":"2246_CR434","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","volume":"576","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Structure and drug resistance of the Plasmodium falciparum transporter PfCRT. Nature 576, 315\u2013320 (2019).","journal-title":"Nature"},{"key":"2246_CR435","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","volume":"8","author":"A Amambua-Ngwa","year":"2023","unstructured":"Amambua-Ngwa, A. et al. Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1. Nat. Microbiol. 8, 1213\u20131226 (2023).","journal-title":"Nat. Microbiol."},{"key":"2246_CR436","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jac\/dkg294","volume":"52","author":"A Aubouy","year":"2003","unstructured":"Aubouy, A. et al. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. J. Antimicrob. Chemother. 52, 43\u201349 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"2246_CR437","doi-asserted-by":"publisher","first-page":"9109","DOI":"10.1073\/pnas.85.23.9109","volume":"85","author":"AF Cowman","year":"1988","unstructured":"Cowman, A. F., Morry, M. J., Biggs, B. A., Cross, G. A. & Foote, S. J. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 85, 9109\u20139113 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR438","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","volume":"85","author":"DS Peterson","year":"1988","unstructured":"Peterson, D. S., Walliker, D. & Wellems, T. E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. USA 85, 9114\u20139118 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR439","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1432-1033.1994.00397.x","volume":"224","author":"DR Brooks","year":"1994","unstructured":"Brooks, D. R. et al. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 224, 397\u2013405 (1994).","journal-title":"Eur. J. Biochem."},{"key":"2246_CR440","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","volume":"94","author":"T Triglia","year":"1997","unstructured":"Triglia, T., Menting, J. G., Wilson, C. & Cowman, A. F. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 94, 13944\u201313949 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR441","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-89","volume":"8","author":"S Picot","year":"2009","unstructured":"Picot, S. et al. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar. J. 8, 89 (2009).","journal-title":"Malar. J."},{"key":"2246_CR442","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1128\/AAC.00024-09","volume":"53","author":"CJ Sutherland","year":"2009","unstructured":"Sutherland, C. J. et al. Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom. Antimicrob. Agents Chemother. 53, 3405\u20133410 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2246_CR443","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2734-x","volume":"18","author":"T Jiang","year":"2019","unstructured":"Jiang, T. et al. High prevalence of Pfdhfr\u2013Pfdhps quadruple mutations associated with sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea. Malar. J. 18, 101 (2019).","journal-title":"Malar. J."},{"key":"2246_CR444","doi-asserted-by":"publisher","first-page":"232","DOI":"10.6026\/97320630014232","volume":"14","author":"IV Singh","year":"2018","unstructured":"Singh, I. V. & Mishra, S. Molecular docking analysis of pyrimethamine derivatives with Plasmodium falciparum dihydrofolate reductase. Bioinformation 14, 232\u2013235 (2018).","journal-title":"Bioinformation"},{"key":"2246_CR445","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01538-21","volume":"66","author":"C Pethrak","year":"2022","unstructured":"Pethrak, C. et al. New insights into antimalarial chemopreventive activity of antifolates. Antimicrob. Agents Chemother. 66, e015382 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2246_CR446","doi-asserted-by":"publisher","first-page":"484","DOI":"10.12688\/wellcomeopenres.20111.1","volume":"8","author":"K Maitland","year":"2023","unstructured":"Maitland, K. et al. SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART). Wellcome Open Res. 8, 484 (2023).","journal-title":"Wellcome Open Res."},{"key":"2246_CR447","doi-asserted-by":"publisher","first-page":"e0188754","DOI":"10.1371\/journal.pone.0188754","volume":"12","author":"AM Leitgeb","year":"2017","unstructured":"Leitgeb, A. M. et al. Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria. PLos One 12, e0188754 (2017).","journal-title":"PLos One"},{"key":"2246_CR448","doi-asserted-by":"publisher","first-page":"e0164895","DOI":"10.1371\/journal.pone.0164895","volume":"11","author":"KR Kesely","year":"2016","unstructured":"Kesely, K. R., Pantaleo, A., Turrini, F. M., Olupot-Olupot, P. & Low, P. S. Inhibition of an erythrocyte tyrosine kinase with imatinib prevents Plasmodium falciparum Egress and terminates parasitemia. PLoS One 11, e0164895 (2016).","journal-title":"PLoS One"},{"key":"2246_CR449","first-page":"357027","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal, N. & Iqbal, N. Imatinib: a breakthrough of targeted therapy in cancer. Chemother. Res Pr. 2014, 357027 (2014).","journal-title":"Chemother. Res Pr."},{"key":"2246_CR450","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/14728222.2023.2185511","volume":"27","author":"HW Ong","year":"2023","unstructured":"Ong, H. W., Adderley, J., Tobin, A. B., Drewry, D. H. & Doerig, C. Parasite and host kinases as targets for antimalarials. Expert Opin. Ther. Targets 27, 151\u2013169 (2023).","journal-title":"Expert Opin. Ther. Targets"},{"key":"2246_CR451","doi-asserted-by":"crossref","unstructured":"Chien, H. D. et al. Imatinib augments standard malaria combination therapy without added toxicity. J. Exp. Med. 218 (2021).","DOI":"10.1084\/jem.20210724"},{"key":"2246_CR452","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijid.2023.11.031","volume":"139","author":"R Varo","year":"2024","unstructured":"Varo, R. et al. Adjunctive rosiglitazone treatment for severe pediatric malaria: a randomized placebo-controlled trial in Mozambican children. Int. J. Infect. Dis. 139, 34\u201340 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"2246_CR453","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1858-0","volume":"16","author":"R Varo","year":"2017","unstructured":"Varo, R. et al. Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria. Malar. J. 16, 215 (2017).","journal-title":"Malar. J."},{"key":"2246_CR454","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2195-7","volume":"17","author":"R Varo","year":"2018","unstructured":"Varo, R. et al. Adjunctive therapy for severe malaria: a review and critical appraisal. Malar. J. 17, 47 (2018).","journal-title":"Malar. J."},{"key":"2246_CR455","doi-asserted-by":"publisher","first-page":"e1003980","DOI":"10.1371\/journal.ppat.1003980","volume":"10","author":"L Serghides","year":"2014","unstructured":"Serghides, L. et al. PPAR\u03b3 agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria. PLoS Pathog. 10, e1003980 (2014).","journal-title":"PLoS Pathog."},{"key":"2246_CR456","doi-asserted-by":"publisher","DOI":"10.1038\/srep27806","volume":"6","author":"GM Goldgof","year":"2016","unstructured":"Goldgof, G. M. et al. Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor. Sci. Rep. 6, 27806 (2016).","journal-title":"Sci. Rep."},{"key":"2246_CR457","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/cid\/ciab716","volume":"74","author":"EK Schmitt","year":"2022","unstructured":"Schmitt, E. K. et al. Efficacy of cipargamin (KAE609) in a randomized, phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria. Clin. Infect. Dis. 74, 1831\u20131839 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR458","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-04009-1","volume":"20","author":"G Ndayisaba","year":"2021","unstructured":"Ndayisaba, G. et al. Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa. Malar. J. 20, 478 (2021).","journal-title":"Malar. J."},{"key":"2246_CR459","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101765","volume":"36","author":"SM Bouwman","year":"2020","unstructured":"Bouwman, S. M. et al. The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound. Travel Med. Infect. Dis. 36, 101765 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"2246_CR460","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1473-3099(21)00679-4","volume":"22","author":"BE Barber","year":"2022","unstructured":"Barber, B. E. et al. Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study. Lancet Infect. Dis. 22, 879\u2013890 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR461","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/cid\/cix1122","volume":"66","author":"G Mombo-Ngoma","year":"2018","unstructured":"Mombo-Ngoma, G. et al. Efficacy and safety of fosmidomycin-piperaquine as nonartemisinin-based combination therapy for uncomplicated falciparum malaria: a single-arm, age de-escalation proof-of-concept study in Gabon. Clin. Infect. Dis. 66, 1823\u20131830 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"2246_CR462","doi-asserted-by":"crossref","unstructured":"Ghyslain, M.-N. et al. Fosmidomycin-piperaquine as non-artemisinin-based combination for acute uncomplicated plasmodium falciparum malaria. BMJ Glob. Health 2, (2017).","DOI":"10.1136\/bmjgh-2016-000260.57"},{"key":"2246_CR463","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S1473-3099(21)00252-8","volume":"21","author":"JS McCarthy","year":"2021","unstructured":"McCarthy, J. S. et al. Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study. Lancet Infect. Dis. 21, 1713\u20131724 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR464","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04171-0","volume":"21","author":"A Khandelwal","year":"2022","unstructured":"Khandelwal, A. et al. Translation of liver stage activity of M5717, a Plasmodium elongation factor 2 inhibitor: from bench to bedside. Malar. J. 21, 151 (2022).","journal-title":"Malar. J."},{"key":"2246_CR465","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1211613","volume":"13","author":"M Parkyn Schneider","year":"2023","unstructured":"Parkyn Schneider, M. et al. The delayed bloodstream clearance of Plasmodium falciparum parasites after M5717 treatment is attributable to the inability to modify their red blood cell hosts. Front. Cell Infect. Microbiol. 13, 1211613 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2246_CR466","doi-asserted-by":"publisher","first-page":"e02181","DOI":"10.1128\/AAC.02181-19","volume":"64","author":"M Rottmann","year":"2020","unstructured":"Rottmann, M. et al. Preclinical antimalarial combination study of M5717, a Plasmodium falciparum elongation factor 2 inhibitor, and pyronaridine, a hemozoin formation inhibitor. Antimicrob. Agents Chemother. 64, e02181\u201319 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2246_CR467","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/jac\/dkad260","volume":"78","author":"WY Chu","year":"2023","unstructured":"Chu, W. Y. & Dorlo, T. P. C. Pyronaridine: a review of its clinical pharmacology in the treatment of malaria. J. Antimicrob. Chemother. 78, 2406\u20132418 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"2246_CR468","first-page":"Cd006404","volume":"6","author":"J Pryce","year":"2022","unstructured":"Pryce, J., Taylor, M., Fox, T. & Hine, P. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst. Rev. 6, Cd006404 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2246_CR469","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-270","volume":"11","author":"SL Croft","year":"2012","unstructured":"Croft, S. L. et al. Review of pyronaridine anti-malarial properties and product characteristics. Malar. J. 11, 2700 (2012).","journal-title":"Malar. J."},{"key":"2246_CR470","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/S2666-5247(21)00192-0","volume":"3","author":"W Stone","year":"2022","unstructured":"Stone, W. et al. Pyronaridine artesunate or dihydroartemisinin piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in a four-arm, single-blind, phase 2\/3, randomised trial. Lancet Microbe 3, e41\u2013e51 (2022).","journal-title":"Lancet Microbe"},{"key":"2246_CR471","doi-asserted-by":"publisher","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","volume":"111","author":"MB Jim\u00e9nez-D\u00edaz","year":"2014","unstructured":"Jim\u00e9nez-D\u00edaz, M. B. et al. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proc. Natl. Acad. Sci. USA 111, E5455\u2013E5462 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2246_CR472","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104065","volume":"80","author":"AH Gaur","year":"2022","unstructured":"Gaur, A. H. et al. Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development. EBioMedicine 80, 104065 (2022).","journal-title":"EBioMedicine"},{"key":"2246_CR473","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S1473-3099(19)30611-5","volume":"20","author":"AH Gaur","year":"2020","unstructured":"Gaur, A. H. et al. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a\/b trial. Lancet Infect. Dis. 20, 964\u2013975 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR474","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04075-z","volume":"21","author":"A SheelaNair","year":"2022","unstructured":"SheelaNair, A. et al. Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice. Malar. J. 21, 49 (2022).","journal-title":"Malar. J."},{"key":"2246_CR475","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/S1473-3099(17)30365-1","volume":"17","author":"OA Koita","year":"2017","unstructured":"Koita, O. A. et al. AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial. Lancet Infect. Dis. 17, 1266\u20131275 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR476","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1093\/jac\/dkab219","volume":"76","author":"F Nardella","year":"2021","unstructured":"Nardella, F. et al. Cross-resistance of the chloroquine-derivative AQ-13 with amodiaquine in Cambodian Plasmodium falciparum isolates. J. Antimicrob. Chemother. 76, 2565\u20132568 (2021).","journal-title":"J. Antimicrob. Chemother."},{"key":"2246_CR477","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13543784.2019.1560419","volume":"28","author":"JB Mengue","year":"2019","unstructured":"Mengue, J. B., Held, J. & Kreidenweiss, A. AQ-13\u2014an investigational antimalarial drug. Expert Opin. Investig. Drugs 28, 217\u2013222 (2019).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"2246_CR478","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2203067","volume":"387","author":"RL Wu","year":"2022","unstructured":"Wu, R. L. et al. Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria. N. Engl. J. Med. 387, 397\u2013407 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2246_CR479","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJMoa2312775","volume":"390","author":"K Kayentao","year":"2024","unstructured":"Kayentao, K. et al. Subcutaneous administration of a monoclonal antibody to prevent malaria. N. Engl. J. Med. 390, 1549\u20131559 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2246_CR480","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(19)30633-4","volume":"20","author":"HC Slater","year":"2020","unstructured":"Slater, H. C. et al. Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study. Lancet Infect. Dis. 20, 498\u2013508 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR481","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14787210.2017.1271713","volume":"15","author":"H Alout","year":"2017","unstructured":"Alout, H. & Foy, B. D. Ivermectin: a complimentary weapon against the spread of malaria?. Expert Rev. Anti Infect. Ther. 15, 231\u2013240 (2017).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"2246_CR482","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(18)32321-3","volume":"393","author":"BD Foy","year":"2019","unstructured":"Foy, B. D. et al. Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial. Lancet 393, 1517\u20131526 (2019).","journal-title":"Lancet"},{"key":"2246_CR483","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/pharmaceutics14102031","volume":"14","author":"J Dormoi","year":"2022","unstructured":"Dormoi, J., Amalvict, R., Gendrot, M. & Pradines, B. Methylene blue-based combination therapy with amodiaquine prevents severe malaria in an experimental rodent model. Pharmaceutics 14, 2031 (2022).","journal-title":"Pharmaceutics"},{"key":"2246_CR484","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/infdis\/jiu540","volume":"211","author":"B Coulibaly","year":"2014","unstructured":"Coulibaly, B. et al. Efficacy and safety of triple combination therapy with artesunate-amodiaquine\u2013methylene blue for Falciparum malaria in cildren: a randomized controlled trial in Burkina Faso. J. Infect. Dis. 211, 689\u2013697 (2014).","journal-title":"J. Infect. Dis."},{"key":"2246_CR485","doi-asserted-by":"publisher","first-page":"e1630","DOI":"10.1371\/journal.pone.0001630","volume":"3","author":"A Zoungrana","year":"2008","unstructured":"Zoungrana, A. et al. Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. Plos One 3, e1630 (2008).","journal-title":"Plos One"},{"key":"2246_CR486","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1473-3099(18)30044-6","volume":"18","author":"A Dicko","year":"2018","unstructured":"Dicko, A. et al. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial. Lancet Infect. Dis. 18, 627\u2013639 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR487","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1108366","volume":"13","author":"C Fabbri","year":"2023","unstructured":"Fabbri, C. et al. The activity of methylene blue against asexual and sexual stages of Plasmodium vivax. Front. Cell Infect. Microbiol. 13, 1108366 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2246_CR488","doi-asserted-by":"crossref","unstructured":"Sangana, R. et al. Pharmacokinetics of ganaplacide and lumefantrine in adults, adolescents, and children with Plasmodium falciparum malaria treated with ganaplacide plus lumefantrine solid dispersion formulation: analysis of data from a multinational phase 2 study. J. Clin. Pharmacol. 65, 179\u2013189 (2024).","DOI":"10.1002\/jcph.6138"},{"key":"2246_CR489","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S1473-3099(23)00209-8","volume":"23","author":"B Ogutu","year":"2023","unstructured":"Ogutu, B. et al. Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial. Lancet Infect. Dis. 23, 1051\u20131061 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR490","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1093\/jac\/dkae300","volume":"79","author":"J Manaranche","year":"2024","unstructured":"Manaranche, J. et al. In vitro evaluation of ganaplacide\/lumefantrine combination against Plasmodium falciparum in a context of artemisinin resistance. J. Antimicrob. Chemother. 79, 2877\u20132886 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"2246_CR491","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15440-4","volume":"11","author":"GM LaMonte","year":"2020","unstructured":"LaMonte, G. M. et al. Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway. Nat. Commun. 11, 1780 (2020).","journal-title":"Nat. Commun."},{"key":"2246_CR492","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1473-3099(23)00738-7","volume":"24","author":"R Gonz\u00e1lez","year":"2024","unstructured":"Gonz\u00e1lez, R. et al. Safety and efficacy of dihydroartemisinin piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 24, 476\u2013487 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR493","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1101\/gr.168286.113","volume":"24","author":"S Nair","year":"2014","unstructured":"Nair, S. et al. Single-cell genomics for dissection of complex malaria infections. Genome Res. 24, 1028\u20131038 (2014).","journal-title":"Genome Res."},{"key":"2246_CR494","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1093\/gbe\/evx256","volume":"9","author":"SG Trevino","year":"2017","unstructured":"Trevino, S. G. et al. High-resolution single-cell sequencing of malaria parasites. Genome Biol. Evol. 9, 3373\u20133383 (2017).","journal-title":"Genome Biol. Evol."},{"key":"2246_CR495","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature24280","volume":"551","author":"A Poran","year":"2017","unstructured":"Poran, A. et al. Single-cell RNA sequencing reveals a signature of sexual commitment in malaria parasites. Nature 551, 95\u201399 (2017).","journal-title":"Nature"},{"key":"2246_CR496","doi-asserted-by":"publisher","first-page":"e33105","DOI":"10.7554\/eLife.33105","volume":"7","author":"AJ Reid","year":"2018","unstructured":"Reid, A. J. et al. Single-cell RNA-seq reveals hidden transcriptional variation in malaria parasites. ELife 7, e33105 (2018).","journal-title":"ELife"},{"key":"2246_CR497","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.yexcr.2018.08.003","volume":"371","author":"M Ngara","year":"2018","unstructured":"Ngara, M. et al. Exploring parasite heterogeneity using single-cell RNA-seq reveals a gene signature among sexual stage Plasmodium falciparum parasites. Exp. Cell Res. 371, 130\u2013138 (2018).","journal-title":"Exp. Cell Res."},{"key":"2246_CR498","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00130-18","volume":"3","author":"KA Walzer","year":"2018","unstructured":"Walzer, K. A., Kubicki, D. M., Tang, X. & Chi, J. T. Single-cell analysis reveals distinct gene expression and heterogeneity in male and female Plasmodium falciparum gametocytes. mSphere 3, e00130 (2018).","journal-title":"mSphere"},{"key":"2246_CR499","doi-asserted-by":"publisher","first-page":"70","DOI":"10.12688\/wellcomeopenres.14645.4","volume":"3","author":"NMB Brancucci","year":"2018","unstructured":"Brancucci, N. M. B. et al. Probing Plasmodium falciparum sexual commitment at the single-cell level. Wellcome Open Res. 3, 70 (2018).","journal-title":"Wellcome Open Res."},{"key":"2246_CR500","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41564-018-0291-7","volume":"4","author":"C Bancells","year":"2019","unstructured":"Bancells, C. et al. Revisiting the initial steps of sexual development in the malaria parasite Plasmodium falciparum. Nat. Microbiol. 4, 144\u2013154 (2019).","journal-title":"Nat. Microbiol."},{"key":"2246_CR501","doi-asserted-by":"publisher","first-page":"e1008506","DOI":"10.1371\/journal.pgen.1008506","volume":"15","author":"KA Walzer","year":"2019","unstructured":"Walzer, K. A., Fradin, H., Emerson, L. Y., Corcoran, D. L. & Chi, J. T. Latent transcriptional variations of individual Plasmodium falciparum uncovered by single-cell RNA-seq and fluorescence imaging. PLOS Genet. 15, e1008506 (2019).","journal-title":"PLOS Genet."},{"key":"2246_CR502","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.chom.2021.08.009","volume":"29","author":"A Dia","year":"2021","unstructured":"Dia, A. et al. Single-genome sequencing reveals within-host evolution of human malaria parasites. Cell Host Microbe 29, 1496\u20131506 (2021).","journal-title":"Cell Host Microbe"},{"key":"2246_CR503","doi-asserted-by":"publisher","first-page":"e0000821","DOI":"10.1128\/Spectrum.00008-21","volume":"9","author":"M Rawat","year":"2021","unstructured":"Rawat, M., Srivastava, A., Johri, S., Gupta, I. & Karmodiya, K. Single-cell RNA sequencing reveals cellular heterogeneity and stage transition under temperature stress in synchronized Plasmodium falciparum cells. Microbiol. Spectr. 9, e0000821 (2021).","journal-title":"Microbiol. Spectr."},{"key":"2246_CR504","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23434-z","volume":"12","author":"E Real","year":"2021","unstructured":"Real, E. et al. A single-cell atlas of Plasmodium falciparum transmission through the mosquito. Nat. Commun. 12, 3196 (2021).","journal-title":"Nat. Commun."},{"key":"2246_CR505","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30605-z","volume":"13","author":"J Tripathi","year":"2022","unstructured":"Tripathi, J., Zhu, L., Nayak, S., Stoklasa, M. & Bozdech, Z. Stochastic expression of invasion genes in Plasmodium falciparum schizonts. Nat. Commun. 13, 3004 (2022).","journal-title":"Nat. Commun."},{"key":"2246_CR506","doi-asserted-by":"publisher","first-page":"e03671","DOI":"10.1128\/spectrum.03671-22","volume":"11","author":"M Mohammed","year":"2023","unstructured":"Mohammed, M. et al. Single-cell transcriptomics to define Plasmodium falciparum stage transition in the mosquito midgut. Microbiol. Spectr. 11, e03671\u201303622 (2023).","journal-title":"Microbiol. Spectr."},{"key":"2246_CR507","doi-asserted-by":"publisher","first-page":"e1011929","DOI":"10.1371\/journal.ppat.1011929","volume":"20","author":"E Pollenus","year":"2024","unstructured":"Pollenus, E. et al. Single-cell RNA sequencing reveals endothelial cell killing and resolution pathways in experimental malaria-associated acute respiratory distress syndrome. PLoS Pathog. 20, e1011929 (2024).","journal-title":"PLoS Pathog."},{"key":"2246_CR508","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj4088","volume":"384","author":"SK Dogga","year":"2024","unstructured":"Dogga, S. K. et al. A single cell atlas of sexual development in Plasmodium falciparum. Science 384, eadj4088 (2024).","journal-title":"Science"},{"key":"2246_CR509","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrmicro.2017.47","volume":"15","author":"M Wahlgren","year":"2017","unstructured":"Wahlgren, M., Goel, S. & Akhouri, R. R. Variant surface antigens of Plasmodium falciparum and their roles in severe malaria. Nat. Rev. Microbiol. 15, 479\u2013491 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"2246_CR510","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","volume":"19","author":"WL Hamilton","year":"2019","unstructured":"Hamilton, W. L. et al. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect. Dis. 19, 943\u2013951 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR511","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40935-7","volume":"13","author":"E Rovira-Vallbona","year":"2023","unstructured":"Rovira-Vallbona, E. et al. Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000\u20132016). Sci. Rep. 13, 13948 (2023).","journal-title":"Sci. Rep."},{"key":"2246_CR512","doi-asserted-by":"publisher","first-page":"e1004789","DOI":"10.1371\/journal.ppat.1004789","volume":"11","author":"E Talundzic","year":"2015","unstructured":"Talundzic, E. et al. Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog. 11, e1004789 (2015).","journal-title":"PLoS Pathog."},{"key":"2246_CR513","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/infdis\/jiv752","volume":"213","author":"SM Chenet","year":"2016","unstructured":"Chenet, S. M. et al. Independent emergence of the Plasmodium falciparum Kelch propeller domain mutant allele C580Y in Guyana. J. Infect. Dis. 213, 1472\u20131475 (2016).","journal-title":"J. Infect. Dis."},{"key":"2246_CR514","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun, K. M. et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect. Dis. 15, 415\u2013421 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR515","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana, A. et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat. Med. 26, 1602\u20131608 (2020).","journal-title":"Nat. Med."},{"key":"2246_CR516","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana, A. et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect. Dis. 21, 1120\u20131128 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR517","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3201\/eid2701.203527","volume":"27","author":"C Bergmann","year":"2021","unstructured":"Bergmann, C. et al. Increase in Kelch 13 polymorphisms in Plasmodium falciparum, Southern Rwanda. Emerg. Infect. Dis. 27, 294\u2013296 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"2246_CR518","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","volume":"225","author":"J Straimer","year":"2022","unstructured":"Straimer, J., Gandhi, P., Renner, K. C. & Schmitt, E. K. High Prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine. J. Infect. Dis. 225, 1411\u20131414 (2022).","journal-title":"J. Infect. Dis."},{"key":"2246_CR519","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4269\/ajtmh.15-0477","volume":"94","author":"AG Bayih","year":"2016","unstructured":"Bayih, A. G. et al. A Unique Plasmodium falciparum K13 gene mutation in Northwest Ethiopia. Am. J. Trop. Med. Hyg. 94, 132\u2013135 (2016).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2246_CR520","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","volume":"389","author":"S Mihreteab","year":"2023","unstructured":"Mihreteab, S. et al. Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea. N. Engl. J. Med. 389, 1191\u20131202 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2246_CR521","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","volume":"8","author":"AA Fola","year":"2023","unstructured":"Fola, A. A. et al. Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nat. Microbiol. 8, 1911\u20131919 (2023).","journal-title":"Nat. Microbiol."},{"key":"2246_CR522","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S1473-3099(22)00697-1","volume":"23","author":"V Wasakul","year":"2023","unstructured":"Wasakul, V. et al. Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis. Lancet Infect. Dis. 23, 568\u2013577 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"2246_CR523","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad, M. D. et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N. Engl. J. Med. 389, 722\u2013732 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2246_CR524","doi-asserted-by":"publisher","first-page":"e01818","DOI":"10.1128\/AAC.01818-18","volume":"63","author":"V Asua","year":"2019","unstructured":"Asua, V. et al. Changing molecular markers of antimalarial drug sensitivity across Uganda. Antimicrob. Agents Chemother. 63, e01818 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2246_CR525","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","volume":"223","author":"V Asua","year":"2021","unstructured":"Asua, V. et al. Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda. J. Infect. Dis. 223, 985\u2013994 (2021).","journal-title":"J. Infect. Dis."},{"key":"2246_CR526","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/tmi.13929","volume":"28","author":"M Adam","year":"2023","unstructured":"Adam, M. et al. Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016\u20132020: clinical and genetic studies. Trop. Med. Int. Health 28, 817\u2013829 (2023).","journal-title":"Trop. Med. Int. Health"},{"key":"2246_CR527","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04896-0","volume":"23","author":"C Bakari","year":"2024","unstructured":"Bakari, C. et al. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021. Malar. J. 23, 71 (2024).","journal-title":"Malar. J."},{"key":"2246_CR528","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04812-y","volume":"23","author":"B Jeang","year":"2024","unstructured":"Jeang, B. et al. Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia. Malar. J. 23, 36 (2024).","journal-title":"Malar. J."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02246-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T23:01:51Z","timestamp":1750114911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02246-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":528,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02246-3","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}